No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d1ia2A_, 1.0000, 0.00, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-[(4-METHYLPHENYL)SULFANYL]-24- QUINAZOLINEDIAMINE (GW578)
2, d1ia1A_, 0.9992, 0.14, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-(PHENYLSULFANYL)-24-QUINAZOLINEDIAMINE (GW997)
3, d1m78A_, 0.9991, 0.15, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-CHLORYL-246-QUINAZOLINETRIAMINE (GW1225)
4, d1ia3A_, 0.9991, 0.15, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEX IN WHICH THE DIHYDRONICOTINAMIDE MOIETY OF DIHYDRO-NICOTINAMIDE- ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) IS DISPLACED BY 5- [(4-TERT-BUTYLPHENYL)SULFANYL]-24-QUINAZOLINEDIAMINE (GW995)
5, d1m79A_, 0.9989, 0.16, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-(4-METHOXYPHENOXY)-24-QUINAZOLINEDIAMINE (GW1466)
6, d1ia4A_, 0.9988, 0.18, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEX IN WHICH THE DIHYDRONICOTINAMIDE MOIETY OF DIHYDRO-NICOTINAMIDE- ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) IS DISPLACED BY 5- {[4-(4-MORPHOLINYL)PHENYL]SULFANYL}-24-QUINAZOLINEDIAMIN (GW2021)
7, d1m7aA_, 0.9986, 0.19, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H- PYRROLO[32-F] QUINAZOLINE-13-DIAMINE (GW557)
8, d1aoeA_, 0.9981, 0.22, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 13-DIAMINO-7-(1-ETHYEPROPYE)-7H-PYRRALO-[32- F]QUINAZOLINE (GW345)
9, d1ai9A_, 0.9975, 0.26, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE
10, d4hoeA_, 0.9936, 0.26, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(25-DIMETHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-2 4-DIAMINE (UCP111E)
11, d4hofA_, 0.9907, 0.42, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(2-METHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-24- DIAMINE (UCP111H)
12, d3qlrA1, 0.9833, 0.50, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[(3R)-3-(345-TRIMETHOXYPHENYL)PENT-1-YN-1-YL]PYRIMIDINE-2 4-DIAMINE (UCP112A)
13, d3qlsA1, 0.9801, 0.41, 1.000, 190, 190, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[3-METHYL-3-(345-TRIMETHOXYPHENYL)BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP115A)
14, d3qlwB_, 0.9744, 0.51, 1.000, 190, 190, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(25-DIMETHOXYPHENYL)PROP-1-YN-1-YL]-6-ETHYLPYRIMIDINE-24-DIAMINE (UCP120B)
15, d3qlwA_, 0.9741, 0.72, 1.000, 190, 190, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(25-DIMETHOXYPHENYL)PROP-1-YN-1-YL]-6-ETHYLPYRIMIDINE-24-DIAMINE (UCP120B)
16, d4h97A1, 0.9735, 0.70, 1.000, 190, 190, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- {3-[3-METHOXY-5-(4-METHYLPHENYL)PHENYL]BUT-1-YN-1-YL}-6- METHYLPYRIMIDINE-24-DIAMINE (UCP111D4M)
17, d4h96A_, 0.9701, 0.57, 1.000, 189, 189, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- {3-[3-(23-DIHYDRO-14-BENZODIOXIN-6-YL)-5-METHOXYPHENYL]PROP-1-YN-1- YL}-6-ETHYLPYRIMIDINE-24-DIAMINE (UCP1018)
18, d4h97B1, 0.9700, 0.65, 1.000, 189, 189, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- {3-[3-METHOXY-5-(4-METHYLPHENYL)PHENYL]BUT-1-YN-1-YL}-6- METHYLPYRIMIDINE-24-DIAMINE (UCP111D4M)
19, d4h95B_, 0.9699, 0.65, 1.000, 189, 189, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- ETHYL-5-{3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL}PYRIMIDINE-24-DIAMINE (UCP1006)
20, d4h95A_, 0.9699, 0.66, 1.000, 189, 189, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- ETHYL-5-{3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL}PYRIMIDINE-24-DIAMINE (UCP1006)
21, d1ia4B_, 0.9695, 0.66, 1.000, 189, 189, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEX IN WHICH THE DIHYDRONICOTINAMIDE MOIETY OF DIHYDRO-NICOTINAMIDE- ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) IS DISPLACED BY 5- {[4-(4-MORPHOLINYL)PHENYL]SULFANYL}-24-QUINAZOLINEDIAMIN (GW2021)
22, d1m79B_, 0.9690, 1.19, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-(4-METHOXYPHENOXY)-24-QUINAZOLINEDIAMINE (GW1466)
23, d1ia3B_, 0.9685, 1.19, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEX IN WHICH THE DIHYDRONICOTINAMIDE MOIETY OF DIHYDRO-NICOTINAMIDE- ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) IS DISPLACED BY 5- [(4-TERT-BUTYLPHENYL)SULFANYL]-24-QUINAZOLINEDIAMINE (GW995)
24, d1ia2B_, 0.9675, 1.21, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-[(4-METHYLPHENYL)SULFANYL]-24- QUINAZOLINEDIAMINE (GW578)
25, d4h96B_, 0.9668, 1.22, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- {3-[3-(23-DIHYDRO-14-BENZODIOXIN-6-YL)-5-METHOXYPHENYL]PROP-1-YN-1- YL}-6-ETHYLPYRIMIDINE-24-DIAMINE (UCP1018)
26, d1ia1B_, 0.9662, 0.72, 1.000, 189, 189, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-(PHENYLSULFANYL)-24-QUINAZOLINEDIAMINE (GW997)
27, d1ai9B_, 0.9661, 1.23, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE
28, d1m7aB_, 0.9651, 1.23, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H- PYRROLO[32-F] QUINAZOLINE-13-DIAMINE (GW557)
29, d1m78B_, 0.9643, 1.24, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 5-CHLORYL-246-QUINAZOLINETRIAMINE (GW1225)
30, d1aoeB_, 0.9635, 1.25, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADPH) AND 13-DIAMINO-7-(1-ETHYEPROPYE)-7H-PYRRALO-[32- F]QUINAZOLINE (GW345)
31, d4hoeB_, 0.9610, 1.26, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(25-DIMETHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-2 4-DIAMINE (UCP111E)
32, d4hofB_, 0.9590, 1.29, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(2-METHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-24- DIAMINE (UCP111H)
33, d3qlrB1, 0.9574, 1.31, 1.000, 192, 192, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[(3R)-3-(345-TRIMETHOXYPHENYL)PENT-1-YN-1-YL]PYRIMIDINE-2 4-DIAMINE (UCP112A)
34, d3qlsB1, 0.9552, 1.03, 1.000, 190, 190, CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[3-METHYL-3-(345-TRIMETHOXYPHENYL)BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP115A)
35, d3eelA1, 0.8985, 1.06, 1.000, 190, 190, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-(35-DIMETHYLPHENYL)PHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP11153TM) AND NADPH
36, d3qlxA1, 0.8978, 1.76, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[(3R)-3-(345-TRIMETHOXYPHENYL)PENT-1-YN-1-YL]PYRIMIDINE-2 4-DIAMINE (UCP112A)
37, d3eemA1, 0.8978, 1.77, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-(26-DIMETHYLPHENYL)PHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP111D26M) AND NADPH
38, d3eejB1, 0.8978, 1.77, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-PHENYLPHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP111D) AND NADPH
39, d3eejA1, 0.8978, 1.77, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-PHENYLPHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP111D) AND NADPH
40, d3eemB1, 0.8976, 1.77, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-(26-DIMETHYLPHENYL)PHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP111D26M) AND NADPH
41, d3eekB1, 0.8976, 1.78, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-(4-METHYLPHENYL)PHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP111D4M) AND NADPH
42, d3cseB1, 0.8976, 1.77, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24- DIAMINO-5-(3-(25-DIMETHOXYPHENYL)PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120B)
43, d3qlxB1, 0.8975, 1.76, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[(3R)-3-(345-TRIMETHOXYPHENYL)PENT-1-YN-1-YL]PYRIMIDINE-2 4-DIAMINE (UCP112A)
44, d3eelB1, 0.8974, 1.77, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-(35-DIMETHYLPHENYL)PHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP11153TM) AND NADPH
45, d3cseA1, 0.8974, 1.77, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24- DIAMINO-5-(3-(25-DIMETHOXYPHENYL)PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120B)
46, d3eekA1, 0.8972, 1.77, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH 24-DIAMINO-5- [3-METHYL-3-(3-METHOXY-5-(4-METHYLPHENYL)PHENYL)PROP-1-YNYL]-6- METHYLPYRIMIDINE(UCP111D4M) AND NADPH
47, d4hogA1, 0.8962, 1.77, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(2-METHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-24- DIAMINE (UCP111H)
48, d3roaB1, 0.8961, 1.78, 0.444, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- ETHYL-5-[(3R)-3-[3-METHOXY-5-(MORPHOLIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1004)
49, d3roaA1, 0.8961, 1.78, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- ETHYL-5-[(3R)-3-[3-METHOXY-5-(MORPHOLIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1004)
50, d3qlyB1, 0.8961, 1.79, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[3-METHYL-3-(345-TRIMETHOXYPHENYL)BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP115A)
51, d3qlyA1, 0.8961, 1.78, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- METHYL-5-[3-METHYL-3-(345-TRIMETHOXYPHENYL)BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP115A)
52, d4hogB1, 0.8959, 1.78, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(2-METHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-24- DIAMINE (UCP111H)
53, d3qlzB1, 0.8959, 1.78, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(25-DIMETHOXYPHENYL)PROP-1-YN-1-YL]-6-PROPYLPYRIMIDINE-24- DIAMINE (UCP130B)
54, d3qlzA1, 0.8958, 1.78, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- [3-(25-DIMETHOXYPHENYL)PROP-1-YN-1-YL]-6-PROPYLPYRIMIDINE-24- DIAMINE (UCP130B)
55, d4h98B1, 0.8942, 1.79, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- {3-[3-(23-DIHYDRO-14-BENZODIOXIN-6-YL)-5-METHOXYPHENYL]PROP-1-YN-1- YL}-6-ETHYLPYRIMIDINE-24-DIAMINE (UCP1018)
56, d3ro9B1, 0.8937, 1.79, 0.449, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- ETHYL-5-[(3R)-3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1006)
57, d3ro9A1, 0.8935, 1.75, 0.435, 214, 186, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- ETHYL-5-[(3R)-3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1006)
58, d4h98A1, 0.8919, 1.83, 0.455, 215, 187, CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- {3-[3-(23-DIHYDRO-14-BENZODIOXIN-6-YL)-5-METHOXYPHENYL]PROP-1-YN-1- YL}-6-ETHYLPYRIMIDINE-24-DIAMINE (UCP1018)
59, d3cd2A_, 0.8833, 1.84, 0.439, 215, 187, LIGAND INDUCED CONFORMATIONAL CHANGES IN THE CRYSTAL STRUCTURES OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COMPLEXES WITH FOLATE AND NADP+
60, d2fzhA_, 0.8825, 1.77, 0.441, 214, 186, NEW INSIGHTS INTO DIHYDROFOLATE REDUCTASE INTERACTIONS: ANALYSIS OF PNEUMOCYSTIS CARINII AND MOUSE DHFR COMPLEXES WITH NADPH AND TWO HIGHLY POTENT TRIMETHOPRIM DERIVATIVES
61, d1dyrA_, 0.8816, 1.97, 0.368, 206, 185, THE STRUCTURE OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE TO 1.9 ANGSTROMS RESOLUTION
62, d4ixeD_, 0.8812, 2.04, 0.368, 206, 185, PCDHFR-NADPH-270
63, d1ly4A_, 0.8801, 2.00, 0.362, 205, 185, ANALYSIS OF QUINAZOLINE AND PYRIDO[23D]PYRIMIDINE N9-C10 REVERSED BRIDGE ANTIFOLATES IN COMPLEX WITH NADP+ AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE
64, d1vj3A_, 0.8799, 2.02, 0.368, 206, 185, STRUCTURAL STUDIES ON BIO-ACTIVE COMPOUNDS. CRYSTAL STRUCTURE AND MOLECULAR MODELING STUDIES ON THE PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COFACTOR COMPLEX WITH TAB A HIGHLY SELECTIVE ANTIFOLATE.
65, d1ly3A_, 0.8799, 2.02, 0.362, 205, 185, ANALYSIS OF QUINAZOLINE AND PYRIDOPYRIMIDINE N9-C10 REVERSED BRIDGE ANTIFOLATES IN COMPLEX WITH NADP+ AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE
66, d1dajA_, 0.8799, 1.82, 0.366, 205, 183, COMPARISON OF TERNARY COMPLEXES OF PNEUMOCYSTIS CARINII AND WILD TYPE HUMAN DIHYDROFOLATE REDUCTASE WITH COENZYME NADPH AND A NOVEL CLASSICAL ANTITUMOR FURO[23D]PYRIMIDINE ANTIFOLATE
67, d1d8rA_, 0.8799, 2.04, 0.368, 206, 185,  
68, d1cd2A_, 0.8796, 2.16, 0.366, 206, 186, LIGAND INDUCED CONFORMATIONAL CHANGES IN THE CRYSTAL STRUCTURES OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COMPLEXES WITH FOLATE AND NADP+
69, d3nzcX_, 0.8795, 1.82, 0.366, 205, 183, STRUCTURAL ANALYSIS OF PNEUMOCYSTIS CARINII AND HUMAN DHFR COMPLEXES WITH NADPH AND A SERIES OF FIVE POTENT 5-(OMEGA-CARBOXY(ALKYLOXY) PYRIDO[23-D]PYRIDINE DERIVATIVEA
70, d4qjzD_, 0.8793, 2.03, 0.368, 206, 185, PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE TERNARY COMPLEX WITH NADPH AND THE INHIBITOR 24 (N~6~-METHYL-N~6~-(NAPHTHALEN-1-YL) PYRIDO[23-D]PYRIMIDINE-246-TRIAMINE)
71, d4ixfX_, 0.8793, 2.03, 0.368, 206, 185, PCDHFR-269 F69N VARIANT
72, d4g8zX_, 0.8792, 2.06, 0.368, 206, 185, PCDHFR K37S/F69N DOUBLE MUTANT TMP NADPH TERNARY COMPLEX
73, d3nzbX_, 0.8790, 2.04, 0.368, 206, 185, STRUCTURAL ANALYSIS OF PNEUMOCYSTIS CARINII AND HUMAN DHFR COMPLEXES WITH NADPH AND A SERIES OF POTENT 5-(OMEGA-CARBOXYL(ALKYLOXY) PYRIDO[2-D]PYRIMIDINE DERIVATIVES
74, d3nz9X_, 0.8789, 1.81, 0.366, 206, 183, STRUCTURAL ANALYSIS OF PNEUMOCYSTIS CARINII AND HUMAN DHFR COMPLEXES WITH NADPH AND A SERIES OF FIVE POTENT 5-(OMEGA-CARBOXY(ALKYLOXY) PYRIDO[23-D]PYRIMIDINE DERIVATIVES
75, d1klkA_, 0.8789, 1.83, 0.355, 204, 183, CRYSTAL STRUCTURE OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE TERNARY COMPLEX WITH PT653 AND NADPH
76, d1e26A_, 0.8784, 1.79, 0.372, 206, 183, DESIGN SYNTHESIS AND X-RAY CRYSTAL STRUCTURE OF A POTENT DUAL INHIBITOR OF THYMIDYLATE SYNTHASE AND DIHYDROFOLATE REDUCTASE AS AN ANTITUMOR AGENT.
77, d3nz6X_, 0.8782, 1.93, 0.370, 206, 184, STRUCTURAL ANALYSIS OF PNEUMOCYSTIS CARINII AND HUMAN DHFR COMPLEXES WITH NADPH AND A SERIES OF FIVE POTENT 5-(OMEGA-CARBOXY(ALKYLOXY) PYRIDO[23-D]PYRIMIDINE DERIVATIVES
78, d2cd2A_, 0.8782, 1.94, 0.366, 203, 183, LIGAND INDUCED CONFORMATIONAL CHANGES IN THE CRYSTAL STRUCTURES OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COMPLEXES WITH FOLATE AND NADP+
79, d3nzaX_, 0.8781, 2.08, 0.362, 205, 185, STRUCTURAL ANALYSIS OF PNEUMOCYSTIS CARINII AND HUMAN DHFR COMPLEXES WITH NADPH AND A SERIES OF FIVE POTENT 5-(OMEGA-CARBOXY(ALKYLOXY) PYRIDO[23-D]PYRIMIDINE DERIVATIVES
80, d4ixgX_, 0.8777, 1.98, 0.370, 206, 184, PCDHFR-268-K37S-N69F VARIANT
81, d2fziA_, 0.8770, 1.93, 0.370, 206, 184, NEW INSIGHTS INTO DHFR INTERACTIONS: ANALYSIS OF PNEUMOCYSTIS CARINII AND MOUSE DHFR COMPLEXES WITH NADPH AND TWO HIGHLY POTENT TRIMETHOPRIM DERIVATIVES
82, d1s3yA_, 0.8770, 1.80, 0.372, 206, 183, STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINE ANTIFOLATES IN COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE: CORRELATIONS OF ENZYME SELECTIVITY AND STEREOCHEMISTRY
83, d4cd2A_, 0.8580, 1.78, 0.361, 206, 183, LIGAND INDUCED CONFORMATIONAL CHANGES IN THE CRYSTAL STRUCTURES OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COMPLEXES WITH FOLATE AND NADP+
84, d3td8A_, 0.8564, 1.84, 0.372, 206, 183, STRUCTURAL ANALYSIS OF PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COMPLEX WITH NADPH AND 24-DIAMINO-5-METHYL-6-[2 -(4-CARBOXY-1- PENTYNYL)-5 -METHOXYBENZYL]PYRIDO[23-D]PYRIMIDINE
85, d3k45A_, 0.8260, 1.98, 0.370, 206, 184, ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF 24- DIAMINOFURO[23D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND MOUSE DIHYDROFOLATE REDUCTASE
86, d4m6jA_, 0.8235, 1.91, 0.372, 202, 180, CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE (DHFR) BOUND TO NADPH
87, d3k47A_, 0.8226, 1.44, 0.383, 194, 175, ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF 24- DIAMINOFURO[23-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND MOUSE DIHYDROFOLATE REDUCTASE
88, d2c2sA_, 0.8226, 2.25, 0.367, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24- DIAMINO-5-(1-O-CARBORANYLMETHYL)-6-METHYLPYRIMIDINE A NOVEL BORON CONTAINING NONCLASSICAL ANTIFOLATE
89, d3d80A_, 0.8222, 2.16, 0.354, 184, 175, STRUCTURAL ANALYSIS OF A HOLO ENZYME COMPLEX OF MOUSE DIHYDROFOLATE REDUCTASE WITH NADPH AND A TERNARY COMPLEX WTIH THE POTENT AND SELECTIVE INHIBITOR 24-DIAMINO-6-(2 -HYDROXYDIBENZ[BF]AZEPIN-5-YL) METHYLPTERIDINE
90, d2w3aA_, 0.8222, 2.28, 0.367, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM
91, d2c2tA_, 0.8208, 2.34, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24- DIAMINO-5-((78-DICARBAUNDECABORAN-7-YL)METHYL)-6- METHYLPYRIMIDINE A NOVEL BORON CONTAINING NONCLASSICAL ANTIFOLATE
92, d2w3aB_, 0.8195, 2.31, 0.367, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM
93, d1dr1A_, 0.8183, 2.34, 0.350, 186, 177, 2.2 ANGSTROMS CRYSTAL STRUCTURE OF CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADP+ AND BIOPTERIN
94, d8dfrA_, 0.8181, 2.35, 0.350, 186, 177, REFINED CRYSTAL STRUCTURES OF CHICKEN LIVER DIHYDROFOLATE REDUCTASE. 3 ANGSTROMS APO-ENZYME AND 1.7 ANGSTROMS NADPH HOLO-ENZYME COMPLEX
95, d1dr3A_, 0.8179, 2.22, 0.347, 186, 176, 2.3 ANGSTROMS CRYSTAL STRUCTURE OF CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXED WITH THIONADP+ AND BIOPTERIN
96, d2c2sB_, 0.8173, 2.35, 0.339, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24- DIAMINO-5-(1-O-CARBORANYLMETHYL)-6-METHYLPYRIMIDINE A NOVEL BORON CONTAINING NONCLASSICAL ANTIFOLATE
97, d1dr6A_, 0.8172, 2.36, 0.333, 186, 177, CRYSTAL STRUCTURES OF ORGANOMERCURIAL-ACTIVATED CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXES
98, d2w3mA_, 0.8171, 2.36, 0.333, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND FOLATE
99, d1dr5A_, 0.8171, 2.25, 0.347, 186, 176, CRYSTAL STRUCTURES OF ORGANOMERCURIAL-ACTIVATED CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXES
100, d1u70A_, 0.8170, 2.37, 0.339, 186, 177, UNDERSTANDING THE ROLE OF LEU22 VARIANTS IN METHOTREXATE RESISTANCE: COMPARISON OF WILD-TYPE AND LEU22ARG VARIANT MOUSE AND HUMAN DIHYDROFOLATE REDUCTASE
101, d1dr4A_, 0.8170, 2.40, 0.350, 186, 177, CRYSTAL STRUCTURES OF ORGANOMERCURIAL-ACTIVATED CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXES
102, d4kakB_, 0.8168, 2.24, 0.330, 186, 176, CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3S)-3-[3-METHOXY-5-(PYRIDINE-4-YL)PHENYL]BUT-1- YN-1-YL]PYRIMIDINE-24-DIAMINE (UCP1006)
103, d1dr2A_, 0.8168, 2.36, 0.356, 186, 177, 2.3 ANGSTROMS CRYSTAL STRUCTURE OF CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXED WITH THIONADP+ AND BIOPTERIN
104, d2w3mB_, 0.8167, 2.24, 0.335, 186, 176, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND FOLATE
105, d2c2tB_, 0.8164, 2.40, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24- DIAMINO-5-((78-DICARBAUNDECABORAN-7-YL)METHYL)-6- METHYLPYRIMIDINE A NOVEL BORON CONTAINING NONCLASSICAL ANTIFOLATE
106, d1dr7A_, 0.8162, 2.37, 0.333, 186, 177, CRYSTAL STRUCTURES OF ORGANOMERCURIAL-ACTIVATED CHICKEN LIVER DIHYDROFOLATE REDUCTASE COMPLEXES
107, d4kbnB_, 0.8161, 2.25, 0.347, 186, 176, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3-(35- PYRIMIDINE)]-PHENYL-PROP-1-YN-1-YL}-6-ETHYL-PYRIMIDINE-24DIAMINE
108, d4kbnA_, 0.8158, 2.26, 0.347, 186, 176, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3-(35- PYRIMIDINE)]-PHENYL-PROP-1-YN-1-YL}-6-ETHYL-PYRIMIDINE-24DIAMINE
109, d3nxtA_, 0.8150, 2.25, 0.335, 186, 176, PREFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALTERNATE BINDING MODES OBSERVED FOR THE E-AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 24-DIAMINOFURO[2M3-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE
110, d3d84X_, 0.8146, 2.43, 0.350, 186, 177, STRUCTURAL ANALYSIS OF A HOLO ENZYME COMPLEX OF MOUSE DIHYDROFOLATE REDUCTASE WITH NADPH AND A TERNARY COMPLEX WITH THE POTENT AND SELECTIVE INHIBITOR 2.4-DIAMINO-6-(-2 -HYDROXYDIBENZ[BF]AZEPIN-5- YL)METHYLPTERIDINE
111, d3nxvA_, 0.8140, 2.25, 0.347, 186, 176, PREFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 24-DIAMINOFURO[23-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE
112, d4kfjB_, 0.8136, 2.42, 0.345, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3- METHOXY-5-(ISOQUIN-5-YL)PHENYL]PROP-1-YN-1-YL}6-ETHYLPRIMIDINE-24- DIAMINE
113, d3nxoA_, 0.8136, 2.39, 0.367, 186, 177, PERFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 24-DIAMINOFURO[23-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE
114, d4kakA_, 0.8135, 2.43, 0.345, 186, 177, CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3S)-3-[3-METHOXY-5-(PYRIDINE-4-YL)PHENYL]BUT-1- YN-1-YL]PYRIMIDINE-24-DIAMINE (UCP1006)
115, d4kebB_, 0.8131, 2.42, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3- METHOXY-5-(ISOQUIN-5-YL)PHENYL]BUT-1-YN-1-YL}6-ETHYLPYRIMIDINE-24- DIAMINE
116, d1u71A_, 0.8131, 2.43, 0.339, 186, 177, UNDERSTANDING THE ROLE OF LEU22 VARIANTS IN METHOTREXATE RESISTANCE: COMPARISON OF WILD-TYPE AND LEU22ARG VARIANT MOUSE AND HUMAN DIHYDROFOLATE REDUCTASE TERNARY CRYSTAL COMPLEXES WITH METHOTREXATE AND NADPH
117, d4kebA_, 0.8129, 2.29, 0.347, 186, 176, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3- METHOXY-5-(ISOQUIN-5-YL)PHENYL]BUT-1-YN-1-YL}6-ETHYLPYRIMIDINE-24- DIAMINE
118, d1bozA_, 0.8129, 2.43, 0.350, 186, 177, STRUCTURE-BASED DESIGN AND SYNTHESIS OF LIPOPHILIC 24- DIAMINO-6-SUBSTITUTED QUINAZOLINES AND THEIR EVALUATION AS INHIBITORS OF DIHYDROFOLATE REDUCTASE AND POTENTIAL ANTITUMOR AGENTS
119, d2w3bB_, 0.8127, 2.47, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND A LIPOPHILIC ANTIFOLATE SELECTIVE FOR MYCOBACTERIUM AVIUM DHFR 6-((25-DIETHOXYPHENYL)AMINOMETHYL)-24-DIAMINO-5- METHYLPYRIDO(23-D)PYRIMIDINE (SRI-8686)
120, d4qhvA_, 0.8121, 2.28, 0.347, 186, 176, CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE AS COMPLEX WITH PYRIDOPYRIMIDINE 22 (N~6~-METHYL-N~6~-[4-(PROPAN-2-YL) PHENYL]PYRIDO[23-D]PYRIMIDINE-246-TRIAMINE)
121, d3dgaB_, 0.8120, 2.46, 0.350, 186, 177, WILD-TYPE PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH RJF01302 NADPH AND DUMP
122, d1hfrA_, 0.8119, 2.46, 0.350, 186, 177, COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE
123, d4kfjA_, 0.8118, 2.43, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3- METHOXY-5-(ISOQUIN-5-YL)PHENYL]PROP-1-YN-1-YL}6-ETHYLPRIMIDINE-24- DIAMINE
124, d4m6lA_, 0.8117, 2.44, 0.345, 186, 177, CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE (DHFR) BOUND TO NADP+ AND 510-DIDEAZATETRAHYDROFOLIC ACID
125, d3s3vA_, 0.8115, 2.28, 0.309, 224, 175, HUMAN DIHYDROFOLATE REDUCTASE Q35K/N64F DOUBLE MUTANT BINARY COMPLEX WITH TRIMETHOPRIM
126, d1pd8A_, 0.8115, 2.48, 0.350, 186, 177, ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5- METHYL-6-N-METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATE COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE
127, d1hfpA_, 0.8115, 2.30, 0.347, 186, 176, COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE
128, d1s3wA_, 0.8114, 2.33, 0.347, 186, 176, STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINE ANTIFOALTES IN COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE: CORRELATIONS OF ENZYME SELECTIVITY AND STEREOCHEMISTRY
129, d3l3rA_, 0.8113, 2.45, 0.356, 186, 177, STRUCTURAL COMPUTATIONAL AND KINETIC DATA FOR ANTIFOLATE INTERACTIONS AGAINST PNEUMOCYSTIS JIROVECII PNEUMOCYSTIS CARINII AND HUMAN DIHYDROFOLATE REDUCTASE AND THEIR ACTIVE SITE MUTANTS
130, d1u72A_, 0.8113, 2.48, 0.350, 186, 177, UNDERSTANDING THE ROLE OF LEU22 VARIANTS IN METHOTREXATE RESISTANCE: COMPARISON OF WILD-TYPE AND LEU22ARG VARIANT MOUSE AND HUMAN DIHYDRFOLATE REDUCTASE TERNARY CRYSTAL COMPLEXES WITH METHOTREXATE AND NADPH
131, d1dlsA_, 0.8111, 2.49, 0.345, 186, 177, METHOTREXATE-RESISTANT VARIANTS OF HUMAN DIHYDROFOLATE REDUCTASE WITH SUBSTITUTION OF LEUCINE 22: KINETICS CRYSTALLOGRAPHY AND POTENTIAL AS SELECTABLE MARKERS
132, d1pd9A_, 0.8110, 2.48, 0.350, 186, 177, ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5- METHYL-6-N-METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATE COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE
133, d2fzjA_, 0.8109, 2.45, 0.350, 186, 177, NEW INSIGHTS INTO DHFR INTERACTIONS: ANALYSIS OF PNEUMOCYSTIS CARINII AND MOUSE DHFR COMPLEXES WITH NADPH AND TWO HIGHLY POTENT TRIMETHOPRIM DERIVATIVES
134, d1hfqA_, 0.8109, 2.49, 0.350, 186, 177, COMPARISON OF TERNARY CRYSTAL COMPLEXES OF HUMAN DIHYDROFOLATE REDUCTASE WITH NADPH AND A CLASSICAL ANTITUMOR FUROPYRIMDINE
135, d2w3bA_, 0.8108, 2.49, 0.345, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND A LIPOPHILIC ANTIFOLATE SELECTIVE FOR MYCOBACTERIUM AVIUM DHFR 6-((25-DIETHOXYPHENYL)AMINOMETHYL)-24-DIAMINO-5- METHYLPYRIDO(23-D)PYRIMIDINE (SRI-8686)
136, d1dlrA_, 0.8107, 2.50, 0.350, 186, 177, METHOTREXATE-RESISTANT VARIANTS OF HUMAN DIHYDROFOLATE REDUCTASE WITH SUBSTITUTION OF LEUCINE 22: KINETICS CRYSTALLOGRAPHY AND POTENTIAL AS SELECTABLE MARKERS
137, d3nxrA_, 0.8106, 2.44, 0.367, 186, 177, PERFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 24-DIAMINOFURO[23-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE
138, d3n0hA_, 0.8106, 2.50, 0.345, 186, 177, HDHFR DOUBLE MUTANT Q35S/N64F TRIMETHOPRIM BINARY COMPLEX
139, d3f8zA_, 0.8106, 2.46, 0.350, 185, 177, HUMAN DIHYDROFOLATE REDUCTASE STRUCTURAL DATA WITH ACTIVE SITE MUTANT ENZYME COMPLEXES
140, d3nxxA_, 0.8104, 2.49, 0.350, 186, 177, PREFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALTERNATE BINDING MODES OBSERVED FOR THE E- AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 24-DIAMINOFURO-23-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE
141, d3fs6A_, 0.8103, 2.46, 0.345, 186, 177, CORRELATIONS OF INHIBITOR KINETICS FOR PNEUMOCYSTIS JIROVECII AND HUMAN DIHYDROFOLATE REDUCTASE WITH STRUCTURAL DATA FOR HUMAN ACTIVE SITE MUTANT ENZYME COMPLEXES
142, d1mvsA_, 0.8103, 2.46, 0.350, 186, 177, ANALYSIS OF TWO POLYMORPHIC FORMS OF A PYRIDO[23- D]PYRIMIDINE N9-C10 REVERSE-BRIDGE ANTIFOLATE BINARY COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE
143, d1ohjA_, 0.8102, 2.46, 0.345, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE MONOCLINIC (P21) CRYSTAL FORM
144, d3dg8B_, 0.8101, 2.47, 0.345, 186, 177, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH RJF670 NADPH AND DUMP
145, d5huiA_, 0.8099, 2.46, 0.345, 186, 177, 6-SUBSTITUTED PYRIDO[32-D]PYRIMIDINE--6-4 -TRIFLUOROMETHOXYPHENYL)
146, d3oafA_, 0.8097, 2.50, 0.350, 186, 177, STRUCTURAL AND KINETIC DATA FOR ANTIFOLATE INTERACTIONS AGAINST PNEUMOCYSTIS JIROVECII PNEUMOCYSTIS CARINII AND HUMAN DIHYDROFOLATE REDUCTASE AND THIER ACTIVE SITE MUTANTS
147, d3f91A_, 0.8096, 2.49, 0.350, 186, 177, STRUCTURAL DATA FOR HUMAN ACTIVE SITE MUTANT ENZYME COMPLEXES
148, d4qjcA_, 0.8094, 2.27, 0.305, 221, 174, HUMAN DIHYDROFOLATE REDUCTASE TERNARY COMPLEX WITH NADPH AND INHIBITOR 26 (N~6~-METHYL-N~6~-(345-TRIFLUOROPHENYL)PYRIDO[23-D]PYRIMIDINE- 246-TRIAMINE)
149, d1s3uA_, 0.8094, 2.50, 0.345, 186, 177, STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINE ANTIFOLATES IN COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE: CORRELATIONS OF ENZYME SELECTIVITY AND STEREOCHEMISTRY
150, d3s7aA_, 0.8093, 2.47, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE BINARY COMPLEX WITH PT684
151, d5hqzA_, 0.8091, 2.48, 0.350, 186, 177, FLUORINE SUBSTITUTED 5-METHYL-6-(4 -TRIFLUOROMETHOXYPHENYTHIO) THIENO[23-D]PYRIMIDINE-24-DIAMINE
152, d3f8yA_, 0.8091, 2.47, 0.345, 186, 177, CORRELATIONS OF HUMAN DIHYDROFOLATE REDUCTASE WITH STRUCTURAL DATA FOR HUMAN ACTIVE SITE MUTANT ENZYME COMPLEXES
153, d5ht5A_, 0.8089, 2.37, 0.347, 186, 176, 6-SUBSTITUTED PYRROLO[23-D]PYRIMIDINE 6-THIENO-(4-METHOXYPHENYL)
154, d4kd7A_, 0.8089, 2.48, 0.348, 186, 178, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3- METHOXY-5(PYRIDINE-4-YL)PHENYL]PROP-1-YN-1-YL}-6-ETHYL-PYRIMIDINE-2 4-DIAMINE
155, d4kd7B_, 0.8088, 2.48, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-{3-[3- METHOXY-5(PYRIDINE-4-YL)PHENYL]PROP-1-YN-1-YL}-6-ETHYL-PYRIMIDINE-2 4-DIAMINE
156, d3ghwA_, 0.8087, 2.48, 0.350, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE INHIBITOR COMPLEX
157, d5hpbA_, 0.8086, 2.49, 0.345, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE COMPLEX WITH NADPH AND 5-METHYL-6- (PHENYLTHIO-4 TRIFLUOROMETHYL)THIENO[23-D]PYRIMIDINE-24-DIAMINE
158, d3nu0A_, 0.8086, 2.35, 0.341, 186, 176, DESIGN SYNTHESIS BIOLOGICAL EVALUATION AND X-RAY CRYSTAL STRUCTURE OF NOVEL CLASSICAL 656-TRICYCLICBENZO[45]THIENO[23-D]PYRIMIDINES AS DUAL THYMIDYLATE SYNTHASE AND DIHYDROFOLATE REDUCTASE INHIBITORS
159, d2oipA1, 0.8086, 2.37, 0.341, 186, 176, CRYSTAL STRUCTURE OF THE S290G ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
160, d3nzdA_, 0.8085, 2.49, 0.345, 186, 177, STRUCTURAL ANALYSIS OF PNEUMOCYSTIS CARINII AND HUMAN DHFR COMPLEXES WITH NADPH AND A SERIES OF FIVE 5-(OMEGA-CARBOXY(ALKYLOXY(PYRIDO[23- D]PYRIMIDINE DERIVATIVES
161, d3nxyA_, 0.8085, 2.50, 0.339, 186, 177, PREFERENTIAL SELECTION OF ISOMER BINDING FROM CHIRAL MIXTURES: ALERNATE BINDING MODES OBSERVED FRO THE E- AND Z-ISOMERS OF A SERIES OF 5-SUBSTITUTED 24-DIAMINOFURO[23-D]PYRIMIDINES AS TERNARY COMPLEXES WITH NADPH AND HUMAN DIHYDROFOLATE REDUCTASE
162, d3ntzA_, 0.8085, 2.48, 0.345, 186, 177, DESIGN SYNTHESIS BIOLOGICAL EVALUATION AND X-RAY CRYSTAL STRUCTURES OF NOVEL CLASSICAL 656-TRICYCLICBENZO[45]THIENO[23-D]PYRIMIDINES AS DUAL THYMIDYLATE SYNTHASE AND DIHYDROFOLATE REDUCTASE INHIBITORS
163, d1j3iB_, 0.8083, 2.04, 0.289, 178, 173, WILD-TYPE PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH WR99210 NADPH AND DUMP
164, d1pdbA_, 0.8081, 2.50, 0.350, 186, 177, ANALYSIS OF THREE CRYSTAL STRUCTURE DETERMINATIONS OF A 5- METHYL-6-N-METHYLANILINO PYRIDOPYRIMIDINE ANTIFOLATE COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE
165, d1j3jB_, 0.8081, 2.49, 0.350, 186, 177, DOUBLE MUTANT (C59R+S108N) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH PYRIMETHAMINE NADPH AND DUMP
166, d4m6kA_, 0.8079, 2.48, 0.345, 186, 177, CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE (DHFR) BOUND TO NADP+ AND FOLATE
167, d3gyfA_, 0.8079, 2.32, 0.309, 226, 175, HUMAN DHFR WITH Z-ISOMER IN ORTHORHOMBIC LATTICE
168, d3dl5A1, 0.8079, 2.32, 0.309, 226, 175, CRYSTAL STRUCTURE OF THE A287F ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
169, d5ht4A_, 0.8074, 2.50, 0.350, 186, 177, 6-SUBSTITUTED PYRROLO[23-D]PYRIMIDINE 6-THIENO-(4-METHOXYPHENYL)
170, d4ky8D1, 0.8074, 2.34, 0.309, 216, 175, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH METHOTREXATE FDUMP AND 4-((2-AMINO-6-METHYL-4-OXO-47- DIHYDRO-3H-PYRROLO[23-D]PYRIMIDIN-5-YL)THIO)-2-CHLOROPHENYL)-L- GLUTAMIC ACID
171, d3ghcA_, 0.8074, 2.52, 0.350, 186, 177, DESIGN SYNTHESIS AND X-RAY CRYSTAL STRUCTURE OF CLASSICAL AND NONCLASSICAL 2-AMINO-4-OXO-5-SUBSTITUTED-6-THIENO[23- D]PYRIMIDINES AS DUAL THYMIDYLATE SYNTHASE AND DIHYDROFOLATE REDUCTASE INHIBITORS AND AS POTENTIAL ANTITUMOR AGENST
172, d3gi2A_, 0.8072, 2.50, 0.345, 186, 177, HUMAN DIHYDROFOLATE REDUCTASE Q35K MUTANT INHIBITOR COMPLEX
173, d3ghvA_, 0.8072, 2.04, 0.289, 178, 173, HUMAN DIHYDROFOLATE REDUCTASE Q35K/N64F DOUBLE MUTANT INHIBITOR COMPLEX
174, d4ky8B1, 0.8070, 2.50, 0.345, 186, 177, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH METHOTREXATE FDUMP AND 4-((2-AMINO-6-METHYL-4-OXO-47- DIHYDRO-3H-PYRROLO[23-D]PYRIMIDIN-5-YL)THIO)-2-CHLOROPHENYL)-L- GLUTAMIC ACID
175, d4g95A_, 0.8070, 2.05, 0.289, 176, 173, HDHFR-OAG BINARY COMPLEX
176, d5hvbA_, 0.8067, 2.51, 0.345, 186, 177, 5-METHYL-6-(1-NAPHTHYLTHIO)THIENO[23-D]PYRIMIDINE 24-DIAMINE
177, d1s3vA_, 0.8066, 2.50, 0.356, 186, 177, STRUCTURE DETERMINATION OF TETRAHYDROQUINAZOLINE ANTIFOLATES IN COMPLEX WITH HUMAN AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE: CORRELATIONS OF ENZYME SELECTIVITY AND STEREOCHEMISTRY
178, d3dl5E1, 0.8061, 2.50, 0.356, 186, 177, CRYSTAL STRUCTURE OF THE A287F ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
179, d3dl5D1, 0.8061, 2.05, 0.289, 176, 173, CRYSTAL STRUCTURE OF THE A287F ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
180, d5hsrA_, 0.8060, 2.49, 0.345, 186, 177, FLUORINE SUBSTITUTED 5-METHYL-6-(3 4 -DIFLUOROMETHOXYPHENYTHIO) THIENO[23-D]PYRIMIDINE-24-DIAMINE
181, d3dl5B1, 0.8058, 2.52, 0.345, 186, 177, CRYSTAL STRUCTURE OF THE A287F ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
182, d3hj3B1, 0.8057, 2.41, 0.347, 186, 176, CRYSTAL STRUCTURE OF THE CHTS-DHFR F207A NON-ACTIVE SITE MUTANT
183, d3hj3A1, 0.8056, 2.06, 0.289, 178, 173, CRYSTAL STRUCTURE OF THE CHTS-DHFR F207A NON-ACTIVE SITE MUTANT
184, d4q0eE1, 0.8053, 2.08, 0.289, 178, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP AND 2-AMINO-4-OXO-47-DIHYDRO-PYRROLO[23- D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
185, d1j3kB_, 0.8053, 2.52, 0.345, 186, 177, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH WR99210 NADPH AND DUMP
186, d5hqyA_, 0.8052, 2.09, 0.289, 178, 173, HUMAN DIHYDROFOLATE REDUCTASE COMPLEX WITH NADPH AND 5-METHYL-6-(2  3 4 -TRIFLUOROPHENYLTHIO)THIENO[23-D]PYRIMIDINE-24-DIAMINE
187, d4ky8A1, 0.8052, 2.10, 0.289, 178, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH METHOTREXATE FDUMP AND 4-((2-AMINO-6-METHYL-4-OXO-47- DIHYDRO-3H-PYRROLO[23-D]PYRIMIDIN-5-YL)THIO)-2-CHLOROPHENYL)-L- GLUTAMIC ACID
188, d1sejB1, 0.8052, 2.10, 0.289, 178, 173, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM CRYPTOSPORIDIUM HOMINIS BOUND TO 1843U89/NADPH/DUMP
189, d1sejA1, 0.8052, 2.08, 0.289, 176, 173, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM CRYPTOSPORIDIUM HOMINIS BOUND TO 1843U89/NADPH/DUMP
190, d1sejC1, 0.8051, 2.30, 0.305, 221, 174, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM CRYPTOSPORIDIUM HOMINIS BOUND TO 1843U89/NADPH/DUMP
191, d4q0eC1, 0.8050, 2.54, 0.345, 186, 177, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP AND 2-AMINO-4-OXO-47-DIHYDRO-PYRROLO[23- D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
192, d4q0eA1, 0.8050, 2.08, 0.289, 176, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP AND 2-AMINO-4-OXO-47-DIHYDRO-PYRROLO[23- D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
193, d1sejE1, 0.8050, 2.10, 0.289, 178, 173, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM CRYPTOSPORIDIUM HOMINIS BOUND TO 1843U89/NADPH/DUMP
194, d4q0eD1, 0.8049, 2.10, 0.289, 178, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP AND 2-AMINO-4-OXO-47-DIHYDRO-PYRROLO[23- D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
195, d1sejD1, 0.8049, 2.10, 0.289, 178, 173, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM CRYPTOSPORIDIUM HOMINIS BOUND TO 1843U89/NADPH/DUMP
196, p6davA_, 0.8047, 2.08, 0.289, 176, 173, CRYSTAL STRUCTURE OF HUMAN DHFR COMPLEXED WITH NADP AND N10FORMYLTETRAHYDROFOLATE 
197, d4q0eB1, 0.8047, 2.08, 0.289, 176, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP AND 2-AMINO-4-OXO-47-DIHYDRO-PYRROLO[23- D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
198, d4ky8E1, 0.8046, 2.10, 0.289, 178, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH METHOTREXATE FDUMP AND 4-((2-AMINO-6-METHYL-4-OXO-47- DIHYDRO-3H-PYRROLO[23-D]PYRIMIDIN-5-YL)THIO)-2-CHLOROPHENYL)-L- GLUTAMIC ACID
199, d5hveA_, 0.8044, 2.08, 0.289, 176, 173, 5-METHYL-6-(3 -TRIFLUROMETHOXYPHENYLTHIO)[23-D]PYRIMIDINE 24-DIAMINE
200, d2oipD1, 0.8044, 2.10, 0.289, 178, 173, CRYSTAL STRUCTURE OF THE S290G ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
201, d2oipC1, 0.8044, 2.47, 0.347, 186, 176, CRYSTAL STRUCTURE OF THE S290G ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
202, d2oipB1, 0.8044, 2.09, 0.289, 176, 173, CRYSTAL STRUCTURE OF THE S290G ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
203, d1qzfD1, 0.8043, 2.09, 0.289, 176, 173, CRYSTAL STRUCTURE OF DHFR-TS FROM CRYPTOSPORIDIUM HOMINIS
204, d1qzfC1, 0.8043, 2.54, 0.345, 186, 177, CRYSTAL STRUCTURE OF DHFR-TS FROM CRYPTOSPORIDIUM HOMINIS
205, d1qzfB1, 0.8043, 2.09, 0.289, 178, 173, CRYSTAL STRUCTURE OF DHFR-TS FROM CRYPTOSPORIDIUM HOMINIS
206, d1qzfA1, 0.8043, 2.10, 0.289, 178, 173, CRYSTAL STRUCTURE OF DHFR-TS FROM CRYPTOSPORIDIUM HOMINIS
207, d1qzfE1, 0.8042, 2.14, 0.289, 178, 173, CRYSTAL STRUCTURE OF DHFR-TS FROM CRYPTOSPORIDIUM HOMINIS
208, d4ky8C1, 0.8041, 2.12, 0.289, 178, 173, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH METHOTREXATE FDUMP AND 4-((2-AMINO-6-METHYL-4-OXO-47- DIHYDRO-3H-PYRROLO[23-D]PYRIMIDIN-5-YL)THIO)-2-CHLOROPHENYL)-L- GLUTAMIC ACID
209, d3dl5C1, 0.8041, 2.12, 0.289, 178, 173, CRYSTAL STRUCTURE OF THE A287F ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
210, d1kmsA_, 0.8041, 2.12, 0.289, 178, 173, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6- ([5-QUINOLYLAMINO]METHYL)-24-DIAMINO-5-METHYLPYRIDO[23- D]PYRIMIDINE (SRI-9439) A LIPOPHILIC ANTIFOLATE
211, d4ddrA_, 0.8040, 2.12, 0.289, 178, 173, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND P218
212, d5hsuA_, 0.8035, 2.12, 0.289, 178, 173, FLUORINE SUBSTITUTED 5-METHYL-6-(2 4 -DIFLUOROMETHOXYPHENYTHIO) THIENO[23-D]PYRIMIDINE-24-DIAMINE
213, d3dg8A_, 0.8031, 2.12, 0.289, 178, 173, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH RJF670 NADPH AND DUMP
214, d1mvtA_, 0.8031, 2.10, 0.289, 176, 173, ANALYSIS OF TWO POLYMORPHIC FORMS OF A PYRIDO[23- D]PYRIMIDINE N9-C10 REVERSE-BRIDGE ANTIFOLATE BINARY COMPLEX WITH HUMAN DIHYDROFOLATE REDUCTASE
215, d1dhfA_, 0.8031, 2.03, 0.291, 178, 172, CRYSTAL STRUCTURES OF RECOMBINANT HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 5-DEAZOFOLATE
216, d1dhfB_, 0.8030, 2.41, 0.354, 184, 175, CRYSTAL STRUCTURES OF RECOMBINANT HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 5-DEAZOFOLATE
217, d2oipE1, 0.8020, 2.54, 0.350, 186, 177, CRYSTAL STRUCTURE OF THE S290G ACTIVE SITE MUTANT OF TS- DHFR FROM CRYPTOSPORIDIUM HOMINIS
218, d1j3jA_, 0.8017, 2.54, 0.345, 186, 177, DOUBLE MUTANT (C59R+S108N) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH PYRIMETHAMINE NADPH AND DUMP
219, d1kmvA_, 0.8016, 2.43, 0.305, 221, 174, HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (Z)- 6-(2-[25-DIMETHOXYPHENYL]ETHEN-1-YL)-24-DIAMINO-5- METHYLPYRIDO[23-D]PYRIMIDINE (SRI-9662) A LIPOPHILIC ANTIFOLATE
220, d2dhfB_, 0.8014, 2.45, 0.347, 186, 176, CRYSTAL STRUCTURES OF RECOMBINANT HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 5-DEAZOFOLATE
221, p3jsuA1, 0.8011, 2.28, 0.353, 182, 173, QUADRUPLE MUTANT(N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE(PFDHFR-TS) COMPLEXED WITH QN254 NADPH AND DUMP
222, d2dhfA_, 0.8011, 2.30, 0.353, 182, 173, CRYSTAL STRUCTURES OF RECOMBINANT HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 5-DEAZOFOLATE
223, d1j3iA_, 0.8009, 2.11, 0.289, 178, 173, WILD-TYPE PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH WR99210 NADPH AND DUMP
224, d3dgaA_, 0.8008, 2.45, 0.310, 221, 174, WILD-TYPE PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH RJF01302 NADPH AND DUMP
225, d1j3kA_, 0.8005, 2.59, 0.339, 185, 177, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH WR99210 NADPH AND DUMP
226, d1drfA_, 0.8002, 2.31, 0.353, 182, 173, CRYSTAL STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE
227, d1ohkA_, 0.7999, 2.44, 0.305, 221, 174, HUMAN DIHYDROFOLATE REDUCTASE ORTHORHOMBIC (P21 21 21) CRYSTAL FORM
228, d3hj3C1, 0.7991, 2.30, 0.353, 182, 173, CRYSTAL STRUCTURE OF THE CHTS-DHFR F207A NON-ACTIVE SITE MUTANT
229, d3hj3D1, 0.7982, 2.45, 0.310, 223, 174, CRYSTAL STRUCTURE OF THE CHTS-DHFR F207A NON-ACTIVE SITE MUTANT
230, d1yhoA_, 0.7964, 2.47, 0.310, 219, 174, SOLUTION STRUCTURE OF HUMAN DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETHOPRIM AND NADPH 25 STRUCTURES
231, p4dp3A1, 0.7963, 2.46, 0.305, 221, 174, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH P218 AND NADPH
232, d3kjrA1, 0.7961, 2.66, 0.350, 186, 177, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE/THYMIDYLATE SYNTHASE FROM BABESIA BOVIS DETERMINED USING SLIPCHIP BASED MICROFLUIDICS
233, p3kjsD2, 0.7953, 2.50, 0.358, 186, 176, CRYSTAL STRUCTURE OF T. CRUZI DHFR-TS WITH 3 HIGH AFFINITY DHFR INHIBITORS: DQ1 INHIBITOR COMPLEX
234, p3kjsC2, 0.7949, 2.23, 0.289, 178, 173, CRYSTAL STRUCTURE OF T. CRUZI DHFR-TS WITH 3 HIGH AFFINITY DHFR INHIBITORS: DQ1 INHIBITOR COMPLEX
235, d3kjrB1, 0.7940, 2.22, 0.289, 176, 173, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE/THYMIDYLATE SYNTHASE FROM BABESIA BOVIS DETERMINED USING SLIPCHIP BASED MICROFLUIDICS
236, d3nrrB1, 0.7927, 2.46, 0.335, 186, 176, CO-CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM BABESIA BOVIS WITH DUMP RALTITREXED AND NADP
237, d3nrrA1, 0.7926, 2.52, 0.305, 221, 174, CO-CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE FROM BABESIA BOVIS WITH DUMP RALTITREXED AND NADP
238, d2bl9A_, 0.7926, 2.12, 0.269, 183, 171, X-RAY CRYSTAL STRUCTURE OF PLASMODIUM VIVAX DIHYDROFOLATE REDUCTASE IN COMPLEX WITH PYRIMETHAMINE AND ITS DERIVATIVE
239, d2blcA_, 0.7920, 2.53, 0.301, 207, 176, SP21 DOUBLE MUTANT P. VIVAX DIHYDROFOLATE REDUCTASE IN COMPLEX WITH DES-CHLOROPYRIMETHAMINE
240, p3kjsA2, 0.7913, 2.55, 0.301, 211, 176, CRYSTAL STRUCTURE OF T. CRUZI DHFR-TS WITH 3 HIGH AFFINITY DHFR INHIBITORS: DQ1 INHIBITOR COMPLEX
241, d2blaA_, 0.7899, 2.55, 0.301, 211, 176, SP21 DOUBLE MUTANT P. VIVAX DIHYDROFOLATE REDUCTASE IN COMPLEX WITH PYRIMETHAMINE
242, d2blbA_, 0.7886, 2.13, 0.269, 183, 171, X-RAY CRYSTAL STRUCTURE OF PLASMODIUM VIVAX DIHYDROFOLATE REDUCTASE IN COMPLEX WITH PYRIMETHAMINE AND ITS DERIVATIVE
243, d3eigA_, 0.7881, 2.12, 0.269, 185, 171, CRYSTAL STRUCTURE OF A METHOTREXATE-RESISTANT MUTANT OF HUMAN DIHYDROFOLATE REDUCTASE
244, d3k2hA1, 0.7867, 2.13, 0.269, 186, 171, CO-CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE/THYMIDYLATE SYNTHASE FROM BABESIA BOVIS WITH DUMP PEMETREXED AND NADP
245, d3k2hB1, 0.7794, 2.13, 0.269, 186, 171, CO-CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE/THYMIDYLATE SYNTHASE FROM BABESIA BOVIS WITH DUMP PEMETREXED AND NADP
246, d3i3rA1, 0.7600, 2.55, 0.299, 216, 174, X-RAY STRUCTURE DIHYDROFOLATE REDUCTASE/THYMIDYLATE SYNTHASE FROM BABESIA BOVIS AT 2.35A RESOLUTION
247, d3vcoA1, 0.7525, 2.56, 0.299, 215, 174, SCHISTOSOMA MANSONI DIHYDROFOLATE REDUCTASE
248, d3i3rB1, 0.7521, 2.52, 0.297, 203, 175, X-RAY STRUCTURE DIHYDROFOLATE REDUCTASE/THYMIDYLATE SYNTHASE FROM BABESIA BOVIS AT 2.35A RESOLUTION
249, p4kyaH1, 0.7414, 2.53, 0.301, 217, 173, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 3 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
250, p4kyaB1, 0.7413, 2.58, 0.299, 217, 174, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 3 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
251, p4kyaF1, 0.7412, 2.64, 0.335, 186, 176, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 3 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
252, p4eilD1, 0.7407, 2.19, 0.269, 184, 171, CRYSTAL STRUCTURE OF THE LOOP TRUNCATED TOXOPLASMA GONDII TS-DHFR
253, p4eilF1, 0.7405, 2.31, 0.269, 184, 171, CRYSTAL STRUCTURE OF THE LOOP TRUNCATED TOXOPLASMA GONDII TS-DHFR
254, p4ky4A1, 0.7401, 2.15, 0.256, 176, 164, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 2 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
255, p4ky4H1, 0.7399, 2.97, 0.328, 181, 174, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 2 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
256, p4ky4C1, 0.7398, 2.97, 0.328, 181, 174, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 2 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
257, p4eilB1, 0.7393, 2.21, 0.252, 169, 163, CRYSTAL STRUCTURE OF THE LOOP TRUNCATED TOXOPLASMA GONDII TS-DHFR
258, p4ky4B1, 0.7388, 1.96, 0.325, 171, 157, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 2 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
259, d3ia5B_, 0.7381, 1.97, 0.331, 171, 157, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE (DHFR)
260, d3jwkB1, 0.7294, 1.97, 0.325, 171, 157, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (S)-24-DIAMINO-5-(3-METHOXY-3-(3 45-TRIMETHOXYPHENYL)PROP-1-YNYL)-6-METHYLPYRIMIDINE (UCP114A)
261, d3sa2B1, 0.7291, 1.95, 0.331, 171, 157, BACUILLS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND PROPARGYL-LINKED TMP ANALOG UCP1014
262, d3jwcB1, 0.7285, 1.94, 0.325, 171, 157, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-(3-(345- TRIMETHOXYPHENYL)PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120A)
263, d3ia5A_, 0.7285, 1.97, 0.331, 171, 157, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE (DHFR)
264, d3sa1B1, 0.7284, 1.98, 0.331, 171, 157, BACUILLS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND PROPARGYL-LINKED TMP ANALOG UCP1021
265, d3saiB1, 0.7282, 1.98, 0.331, 171, 157, BACUILLS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND TO PROPARGYL-LINKED TMP ANALOG UCP1015
266, d3s9uB1, 0.7282, 1.99, 0.325, 171, 157, BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND TO PROPARGYL-LINKED TMP ANALOG UCP120J
267, d3jwmB1, 0.7282, 1.99, 0.325, 171, 157, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (S)-24-DIAMINO-5-(3-METHOXY-3-(345- TRIMETHOXYPHENYL)PROP-1-YNYL)-6-METHYLPYRIMIDINE (UCP114A)
268, d3jwkA1, 0.7281, 1.97, 0.325, 171, 157, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (S)-24-DIAMINO-5-(3-METHOXY-3-(3 45-TRIMETHOXYPHENYL)PROP-1-YNYL)-6-METHYLPYRIMIDINE (UCP114A)
269, d3jvxB1, 0.7281, 2.11, 0.344, 161, 157, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-(3-(345-TRIMETHOXYPHENYL) PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120A)
270, d2w3vA_, 0.7280, 2.41, 0.346, 162, 159, MYCOBACTERIUM AVIUM DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM
271, d3sa2A1, 0.7279, 2.42, 0.352, 162, 159, BACUILLS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND PROPARGYL-LINKED TMP ANALOG UCP1014
272, d3jwmA1, 0.7277, 2.36, 0.348, 162, 158, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (S)-24-DIAMINO-5-(3-METHOXY-3-(345- TRIMETHOXYPHENYL)PROP-1-YNYL)-6-METHYLPYRIMIDINE (UCP114A)
273, d3jwcA1, 0.7277, 2.26, 0.340, 159, 156, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-(3-(345- TRIMETHOXYPHENYL)PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120A)
274, d3e0bB1, 0.7277, 2.42, 0.352, 162, 159, BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 2 4-DIAMINO-5-(3-(25-DIMETHOXYPHENYL)PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120B)
275, d3saiA1, 0.7272, 2.43, 0.352, 162, 159, BACUILLS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND TO PROPARGYL-LINKED TMP ANALOG UCP1015
276, d3jvxA1, 0.7271, 2.42, 0.352, 162, 159, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-(3-(345-TRIMETHOXYPHENYL) PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120A)
277, d3sa1A1, 0.7268, 2.43, 0.352, 162, 159, BACUILLS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND PROPARGYL-LINKED TMP ANALOG UCP1021
278, d3s9uA1, 0.7265, 2.42, 0.346, 162, 159, BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE BOUND TO PROPARGYL-LINKED TMP ANALOG UCP120J
279, d3jwfB1, 0.7265, 2.43, 0.352, 162, 159, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (R)-24-DIAMINO-5-(3-HYDROXY-3-(3 45-TRIMETHOXYPHENYL)PROP-1-YNYL)-6-METHYLPYRIMIDINE (UCP113A)
280, d3jwfA1, 0.7265, 2.77, 0.294, 165, 163, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND (R)-24-DIAMINO-5-(3-HYDROXY-3-(3 45-TRIMETHOXYPHENYL)PROP-1-YNYL)-6-METHYLPYRIMIDINE (UCP113A)
281, d3e0bA1, 0.7263, 2.77, 0.294, 165, 163, BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 2 4-DIAMINO-5-(3-(25-DIMETHOXYPHENYL)PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120B)
282, d3jw5B1, 0.7262, 2.43, 0.352, 162, 159, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM
283, d2zzaB_, 0.7260, 2.44, 0.352, 162, 159, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE COMPLEX WITH NADP+ AND FOLATE
284, d3jw5A1, 0.7259, 2.43, 0.346, 162, 159, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (Y102F) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM
285, d2zzaA_, 0.7259, 2.43, 0.352, 162, 159, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE COMPLEX WITH NADP+ AND FOLATE
286, d4eleF1, 0.7257, 2.44, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
287, d2w3wA_, 0.7256, 2.44, 0.352, 162, 159, MYCOBACTERIUM AVIUM DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND A LIPOPHILIC ANTIFOLATE SELECTIVE FOR M. AVIUM DHFR 6-((25-DIETHOXYPHENYL)AMINOMETHYL)-24-DIAMINO-5- METHYLPYRIDO(23-D)PYRIMIDINE (SRI-8686)
288, d3ia4A_, 0.7253, 2.45, 0.352, 162, 159, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE (DHFR) IN COMPLEX WITH NADPH AND METHOTREXATE (MTX)
289, d3ix9A_, 0.7250, 2.45, 0.352, 162, 159, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE DIHYDROFOLATE REDUCTASE - SP9 MUTANT
290, d4elbF1, 0.7248, 2.45, 0.346, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
291, d3jw3B1, 0.7248, 2.39, 0.348, 162, 158, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (F96I) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM
292, d4elfF1, 0.7246, 2.45, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
293, d4elhF1, 0.7243, 2.44, 0.346, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
294, d3jw3A1, 0.7238, 2.28, 0.344, 161, 157, CRYSTAL STRUCTURE OF BACILLUS ANTHRACIS (F96I) DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND TRIMETHOPRIM
295, d3dfrA_, 0.7236, 2.45, 0.346, 162, 159, CRYSTAL STRUCTURES OF ESCHERICHIA COLI AND LACTOBACILLUS CASEI DIHYDROFOLATE REDUCTASE REFINED AT 1.7 ANGSTROMS RESOLUTION. I. GENERAL FEATURES AND BINDING OF METHOTREXATE
296, d3tq8A1, 0.7233, 2.29, 0.350, 161, 157, STRUCTURE OF THE DIHYDROFOLATE REDUCTASE (FOLA) FROM COXIELLA BURNETII IN COMPLEX WITH TRIMETHOPRIM
297, p5t7oC2, 0.7232, 2.42, 0.352, 162, 159, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI DIHYDROFOLATE REDUCTASE- THYMIDYLATE SYNTHASE IN COMPLEX WITH (6S)-5678-TETRAHYDROFOLATE
298, d3ia4B_, 0.7232, 2.73, 0.302, 164, 162, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE (DHFR) IN COMPLEX WITH NADPH AND METHOTREXATE (MTX)
299, d4elgF1, 0.7229, 2.30, 0.344, 161, 157, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
300, d1diuA_, 0.7229, 2.40, 0.262, 166, 160, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEX WITH BRODIMOPRIM-46-DICARBOXYLATE
301, d4elbG1, 0.7227, 2.40, 0.262, 166, 160, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
302, d1disA_, 0.7227, 2.38, 0.352, 162, 159, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEX WITH BRODIMOPRIM-46-DICARBOXYLATE
303, d4elbB1, 0.7226, 2.46, 0.358, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
304, d3ix9B_, 0.7223, 2.42, 0.352, 162, 159, CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE DIHYDROFOLATE REDUCTASE - SP9 MUTANT
305, d3fl8F1, 0.7222, 2.43, 0.352, 162, 159, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
306, d4elhB1, 0.7220, 2.48, 0.358, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
307, d3ia4D_, 0.7219, 2.43, 0.253, 162, 158, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE (DHFR) IN COMPLEX WITH NADPH AND METHOTREXATE (MTX)
308, d3ia4C_, 0.7218, 2.51, 0.266, 159, 158, MORITELLA PROFUNDA DIHYDROFOLATE REDUCTASE (DHFR) IN COMPLEX WITH NADPH AND METHOTREXATE (MTX)
309, d3fl8A1, 0.7218, 2.51, 0.266, 159, 158, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
310, d3fl8B1, 0.7217, 2.77, 0.307, 192, 163, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
311, d3fl8G1, 0.7215, 2.34, 0.344, 161, 157, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
312, d4elhG1, 0.7214, 2.45, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
313, d4elgB1, 0.7213, 2.43, 0.253, 162, 158, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
314, d4elbE1, 0.7213, 2.45, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
315, d3fl8E1, 0.7212, 2.44, 0.253, 162, 158, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
316, d4elgG1, 0.7211, 2.40, 0.354, 162, 158, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
317, d3fl8D1, 0.7209, 2.47, 0.264, 166, 159, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
318, d4elhE1, 0.7208, 2.47, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
319, d2qk8A_, 0.7207, 2.47, 0.352, 162, 159, CRYSTAL STRUCTURE OF THE ANTHRAX DRUG TARGET BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE
320, d4elhD1, 0.7206, 2.38, 0.344, 161, 157, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
321, d4eleB1, 0.7206, 2.41, 0.344, 160, 157, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
322, d3fl8C1, 0.7206, 2.48, 0.352, 162, 159, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
323, d3r33A_, 0.7205, 2.48, 0.352, 162, 159, EVIDENCE FOR DYNAMIC MOTION IN PROTEINS AS A MECHANISM FOR LIGAND DISSOCIATION
324, d4elfG1, 0.7204, 2.48, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
325, d4elgA1, 0.7203, 2.47, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
326, d4elfB1, 0.7203, 2.47, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
327, d4eleG1, 0.7203, 2.48, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
328, d3kfyA_, 0.7200, 2.48, 0.352, 162, 159, DYNAMIC SWITCHING AND PARTIAL OCCUPANCIES OF A SMALL MOLECULE INHIBITOR COMPLEX OF DHFR
329, d4elhA1, 0.7199, 2.49, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
330, d4elfE1, 0.7199, 2.49, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
331, d3tqaA_, 0.7199, 2.50, 0.352, 162, 159, STRUCTURE OF THE DIHYDROFOLATE REDUCTASE (FOLA) FROM COXIELLA BURNETII IN COMPLEX WITH NADPH
332, d4elgD1, 0.7198, 2.53, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
333, d4elgE1, 0.7196, 2.50, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
334, d4eleD1, 0.7196, 2.49, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
335, d4eleE1, 0.7194, 2.49, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
336, d4eleA1, 0.7194, 2.19, 0.303, 159, 155, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
337, d4elfA1, 0.7193, 2.49, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
338, d4elbC1, 0.7193, 2.49, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
339, d4elgH1, 0.7191, 2.49, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
340, d4elfD1, 0.7191, 2.49, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
341, d4elbD1, 0.7191, 2.20, 0.303, 159, 155, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
342, d5uioD_, 0.7189, 2.51, 0.352, 162, 159, STRUCTURE OF DHFR WITH BOUND DAP P-ABG AND NADP
343, d4elbA1, 0.7189, 2.52, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
344, d4elhH1, 0.7187, 2.48, 0.268, 158, 157, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
345, d2anqA_, 0.7182, 2.51, 0.352, 162, 159, CRYSTAL STRUCTURE OF E.COLI DHFR IN COMPLEX WITH NADPH AND THE INHIBITOR COMPOUND 10A.
346, d4osgA_, 0.7178, 2.52, 0.352, 162, 159, KLEBSIELLA PNEUMONIAE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3R)-3-[3- METHOXYL-5-(PYRIDINE-4-YL)PHENYL]BUT-1-YN-1-YL]PYRIMIDINE-24-DIAMINE (UCP1006)
347, d1ao8A_, 0.7176, 2.51, 0.346, 162, 159, DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE NMR 21 STRUCTURES
348, d5w3qA_, 0.7175, 2.52, 0.352, 162, 159, L28F E.COLI DHFR IN COMPLEX WITH NADPH
349, d4elbH1, 0.7175, 2.53, 0.340, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
350, d1rx1A_, 0.7175, 2.52, 0.352, 162, 159, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM)
351, d4elhC1, 0.7173, 2.53, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
352, d1rx9A_, 0.7173, 2.49, 0.340, 162, 159, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
353, d4eleH1, 0.7172, 2.52, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
354, d4elfH1, 0.7168, 2.51, 0.346, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
355, d1rx3A_, 0.7168, 2.27, 0.306, 160, 157, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM)
356, d4elgC1, 0.7165, 2.53, 0.340, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
357, d4eleC1, 0.7164, 2.52, 0.352, 162, 159, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
358, d1zdrA_, 0.7164, 2.22, 0.303, 159, 155, DHFR FROM BACILLUS STEAROTHERMOPHILUS
359, d3fl9D1, 0.7163, 2.06, 0.305, 159, 154, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
360, d4elfC1, 0.7162, 2.48, 0.253, 162, 158, STRUCTURE-ACTIVITY RELATIONSHIP GUIDES ENANTIOMERIC PREFERENCE AMONG POTENT INHIBITORS OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE
361, d3qyoA_, 0.7162, 2.48, 0.253, 162, 158, SENSITIVITY OF RECEPTOR INTERNAL MOTIONS TO LIGAND BINDING AFFINITY AND KINETIC OFF-RATE
362, d3datA_, 0.7159, 2.06, 0.305, 159, 154, CRYSTAL STRUCTURE OF THE TERNARY MTX NADPH COMPLEX OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE
363, d2anoA_, 0.7149, 2.50, 0.340, 162, 159, CRYSTAL STRUCTURE OF E.COLI DIHYDROFOLATE REDUCTASE IN COMPLEX WITH NADPH AND THE INHIBITOR MS-SH08-17
364, d3ql3A_, 0.7148, 2.07, 0.305, 159, 154, RE-REFINED COORDINATES FOR PDB ENTRY 1RX2
365, d4gh8B_, 0.7147, 2.53, 0.352, 162, 159, CRYSTAL STRUCTURE OF A  HUMANIZED  E. COLI DIHYDROFOLATE REDUCTASE
366, d4osgC_, 0.7146, 2.06, 0.305, 159, 154, KLEBSIELLA PNEUMONIAE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3R)-3-[3- METHOXYL-5-(PYRIDINE-4-YL)PHENYL]BUT-1-YN-1-YL]PYRIMIDINE-24-DIAMINE (UCP1006)
367, d4pdjA_, 0.7143, 2.52, 0.340, 162, 159, NEUTRON CRYSTAL STRUCTURE OF E.COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND NADP+
368, d4p3qA_, 0.7142, 2.55, 0.340, 162, 159, ROOM-TEMPERATURE WT DHFR TIME-AVERAGED ENSEMBLE
369, d1rx2A_, 0.7140, 2.18, 0.310, 159, 155, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH WITH FOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
370, d1rx8A_, 0.7138, 2.54, 0.352, 162, 159, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 2 - MONOPHOSPHOADENOSINE 5 -DIPHOSPHORIBOSE
371, d1drhA_, 0.7137, 2.54, 0.352, 162, 159, ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 5- DEAZAFOLATE AND 510-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS
372, d4nx6A_, 0.7129, 2.24, 0.301, 161, 153, SINGLE ROOM TEMPERATURE MODEL OF DHFR
373, d7dfrA_, 0.7128, 2.46, 0.354, 161, 158, CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. THE NADP+ HOLOENZYME AND THE FOLATE(DOT)NADP+ TERNARY COMPLEX. SUBSTRATE BINDING AND A MODEL FOR THE TRANSITION STATE
374, d4or7A1, 0.7126, 2.54, 0.352, 162, 159, KLEBSIELLA PNEUMONIAE DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-{3-[3-(PYRIMIDIN-5-YL)PHENYL]PROP-1-YN-1-YL}PYRIMIDINE-24- DIAMINE
375, d3fl9C1, 0.7126, 2.24, 0.303, 159, 155, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
376, d3dauA_, 0.7124, 2.60, 0.352, 161, 159, CRYSTAL STRUCTURE OF THE TERNARY MTX NADPH COMPLEX OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE
377, d2d0kB_, 0.7124, 2.10, 0.305, 159, 154, METHIONINE-FREE MUTANT OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE
378, d4p3rA_, 0.7122, 2.09, 0.305, 159, 154, CRYOGENIC WT DHFR TIME-AVERAGED ENSEMBLE
379, d3fl9F1, 0.7122, 2.28, 0.312, 162, 157, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
380, d4km2B_, 0.7121, 2.28, 0.310, 159, 155, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN AN OPEN CONFORMATION IN COMPLEX WITH TRIMETHOPRIM
381, d4m7uA1, 0.7120, 2.10, 0.305, 159, 154, DIHYDROFOLATE REDUCTASE FROM ENTEROCOCCUS FAECALIS COMPLEXED WITH NADP(H)
382, d4gh8A_, 0.7119, 2.10, 0.305, 159, 154, CRYSTAL STRUCTURE OF A  HUMANIZED  E. COLI DIHYDROFOLATE REDUCTASE
383, d3qylA_, 0.7118, 2.10, 0.305, 159, 154, SENSITIVITY OF RECEPTOR INTERNAL MOTIONS TO LIGAND BINDING AFFINITY AND KINETIC OFF-RATE
384, d4nx7A_, 0.7117, 2.10, 0.305, 159, 154, SINGLE CRYOGENIC TEMPERATURE MODEL OF DHFR
385, d1dreA_, 0.7117, 2.20, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
386, d4km2A_, 0.7116, 2.11, 0.305, 159, 154, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN AN OPEN CONFORMATION IN COMPLEX WITH TRIMETHOPRIM
387, d1rh3A_, 0.7115, 2.32, 0.308, 159, 156, DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM)
388, d3fl9G1, 0.7114, 2.35, 0.308, 159, 156, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
389, d3fl9H1, 0.7113, 2.53, 0.361, 161, 158, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
390, d3fl9E1, 0.7110, 2.33, 0.308, 159, 156, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
391, d4p66A_, 0.7109, 2.50, 0.293, 159, 157, ELECTROSTATICS OF ACTIVE SITE MICROENVIRONMENTS OF E. COLI DHFR
392, d3sh2A_, 0.7106, 2.30, 0.308, 159, 156, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-(3-(4-METHOXYBIPHENYL-3-YL)PROP-1-YNYL)PYRIMIDINE-24- DIAMINE (UCP120J)
393, d4p68A_, 0.7105, 2.53, 0.342, 161, 158, ELECTROSTATICS OF ACTIVE SITE MICROENVIRONMENTS FOR E. COLI DHFR
394, d4fggA1, 0.7105, 2.84, 0.277, 159, 159, S. AUREUS DIHYDROFOLATE REDUCTASE CO-CRYSTALLIZED WITH PROPYL-DAP ISOBUTENYL-DIHYDROPHTHALAZINE INHIBITOR
395, d3sh2B_, 0.7105, 2.55, 0.287, 162, 157, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-(3-(4-METHOXYBIPHENYL-3-YL)PROP-1-YNYL)PYRIMIDINE-24- DIAMINE (UCP120J)
396, d1bzfA_, 0.7104, 2.24, 0.314, 162, 156, NMR SOLUTION STRUCTURE AND DYNAMICS OF THE COMPLEX OF LACTOBACILLUS CASEI DIHYDROFOLATE REDUCTASE WITH THE NEW LIPOPHILIC ANTIFOLATE DRUG TRIMETREXATE 22 STRUCTURES
397, d2lf1A_, 0.7103, 2.24, 0.314, 162, 156, SOLUTION STRUCTURE OF L. CASEI DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH 30 STRUCTURES
398, d3fl9A1, 0.7102, 2.20, 0.303, 159, 155, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
399, d4osgB_, 0.7100, 2.20, 0.303, 159, 155, KLEBSIELLA PNEUMONIAE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3R)-3-[3- METHOXYL-5-(PYRIDINE-4-YL)PHENYL]BUT-1-YN-1-YL]PYRIMIDINE-24-DIAMINE (UCP1006)
400, d4fghA1, 0.7097, 2.34, 0.308, 159, 156, S. AUREUS DIHYDROFOLATE REDUCTASE CO-CRYSTALLIZED WITH ETHYL-DAP ISOBUTENYL-DIHYDROPHTHALAZINE INHIBITOR
401, d4pszA_, 0.7094, 2.90, 0.277, 159, 159,  
402, d4rgcA_, 0.7093, 2.23, 0.303, 159, 155, 277K CRYSTAL STRUCTURE OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE
403, d3fqcA_, 0.7092, 2.47, 0.344, 160, 157, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(345-TRIMETHOXYPHENYL)PENT-1-YNYL]-6- METHYLPYRIMIDINE (UCP115A)
404, d4ptjA_, 0.7091, 2.48, 0.357, 160, 157, ENSEMBLE MODEL FOR ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE AT 277K
405, d3lg4A_, 0.7089, 2.48, 0.357, 160, 157, STAPHYLOCOCCUS AUREUS V31Y F92I MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-[(3S)-3-(5-METHOXY-2 6 -DIMETHYLBIPHENYL- 3-YL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-24-DIAMINE
406, d3lg4B_, 0.7088, 2.10, 0.301, 158, 153, STAPHYLOCOCCUS AUREUS V31Y F92I MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5-[(3S)-3-(5-METHOXY-2 6 -DIMETHYLBIPHENYL- 3-YL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-24-DIAMINE
407, d1zdrB_, 0.7088, 2.25, 0.301, 157, 153, DHFR FROM BACILLUS STEAROTHERMOPHILUS
408, d3frfX_, 0.7085, 2.11, 0.301, 158, 153, S. AUREUS DHFR COMPLEXED WITH NADPH AND ICLAPRIM
409, d1ludA_, 0.7081, 2.40, 0.284, 159, 155, SOLUTION STRUCTURE OF DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETHOPRIM AND NADPH 24 STRUCTURES
410, d4km0B1, 0.7080, 2.25, 0.301, 157, 153, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH PYRIMETHAMINE
411, d4kneB_, 0.7079, 2.38, 0.269, 162, 156, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH CYCLOGUANIL
412, d3fy9X_, 0.7079, 2.39, 0.268, 162, 157, STAPH. AUREUS DHFR F98Y COMPLEXED WITH AR-102
413, d3fraX_, 0.7079, 2.53, 0.363, 160, 157, STAPHYLOCOCCUS AUREUS F98Y DHFR COMPLEXED WITH ICLAPRIM
414, d3fqcB_, 0.7079, 2.17, 0.305, 159, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(345-TRIMETHOXYPHENYL)PENT-1-YNYL]-6- METHYLPYRIMIDINE (UCP115A)
415, d5eccB_, 0.7077, 2.41, 0.284, 159, 155, KLEBSIELLA PNEUMONIAE DFRA1 COMPLEXED WITH NADPH AND 6-ETHYL-5-(3-(2- METHOXY-5-(PYRIDIN-4-YL)PHENYL)PROP-1-YN-1-YL)PYRIMIDINE-24-DIAMINE
416, d4psyA_, 0.7076, 2.10, 0.307, 158, 153, 100K CRYSTAL STRUCTURE OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE
417, d5ecxB_, 0.7075, 2.11, 0.307, 158, 153, KLEBSIELLA PNEUMONIAE DFRA1 COMPLEXED WITH NADPH AND 6-ETHYL-5-(3-(6- (PYRIDIN-4-YL)BENZO[D][13]DIOXOL-4-YL)BUT-1-YN-1-YL)PYRIMIDINE-24- DIAMINE
418, d3fy8X_, 0.7075, 2.29, 0.301, 157, 153, CRYSTAL STRUCTURE OF STAPH. AUREUS DHFR COMPLEXED WITH NADPH AND AR- 101
419, d1vdrA_, 0.7075, 2.10, 0.307, 158, 153, DIHYDROFOLATE REDUCTASE
420, d3ql0A_, 0.7074, 2.42, 0.286, 157, 154, CRYSTAL STRUCTURE OF N23PP/S148A MUTANT OF E. COLI DIHYDROFOLATE REDUCTASE
421, d2d0kA_, 0.7071, 2.42, 0.286, 157, 154, METHIONINE-FREE MUTANT OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE
422, d4osgD_, 0.7070, 2.35, 0.296, 160, 152, KLEBSIELLA PNEUMONIAE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3R)-3-[3- METHOXYL-5-(PYRIDINE-4-YL)PHENYL]BUT-1-YN-1-YL]PYRIMIDINE-24-DIAMINE (UCP1006)
423, d3f0vX_, 0.7070, 2.35, 0.286, 158, 154, STAPHYLOCOCCUS AUREUS F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-5-(26-DIMETHYLPHENYL) PHENYL)BUT-1-YNYL]-6-METHYLPYRIMIDINE
424, d3fyvX_, 0.7067, 2.50, 0.253, 162, 158, STAPH. AUREUS DHFR COMPLEXED WITH NADPH AND AR-102
425, d4lekX_, 0.7066, 2.84, 0.272, 159, 158, STRUCTURE-BASED DESIGN OF NEW DIHYDROFOLATE REDUCTASE ANTIBACTERIAL AGENTS: 7-(BENZIMIDAZOL-1-YL)-24-DIAMINOQUINAZOLINES
426, d5uioA_, 0.7065, 2.95, 0.277, 159, 159, STRUCTURE OF DHFR WITH BOUND DAP P-ABG AND NADP
427, d4kneA_, 0.7065, 2.36, 0.292, 157, 154, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH CYCLOGUANIL
428, d3sqyX_, 0.7065, 2.36, 0.292, 157, 154, S. AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NOVEL 7-ARYL-24- DIAMINOQUINAZOLINES
429, d4lagX_, 0.7064, 2.31, 0.301, 157, 153, STRUCTURE-BASED DESIGN OF NEW DIHYDROFOLATE REDUCTASE ANTIBACTERIAL AGENTS: 7-(BENZIMIDAZOL-1-YL)-24-DIAMINOQUINAZOLINES
430, d4laeX_, 0.7064, 2.39, 0.282, 157, 156, STRUCTURE-BASED DESIGN OF NEW DIHYDROFOLATE REDUCTASE ANTIBACTERIAL AGENTS: 7-(BENZIMIDAZOL-1-YL)-24-DIAMINOQUINAZOLINES
431, d4km0A1, 0.7064, 2.22, 0.312, 158, 154, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH PYRIMETHAMINE
432, d3srsX_, 0.7064, 2.39, 0.282, 157, 156, S. AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NOVEL 7-ARYL-24- DIAMINOQUINAZOLINES
433, d3srrX_, 0.7064, 2.37, 0.292, 157, 154, S. AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NOVEL 7-ARYL-24- DIAMINOQUINAZOLINES
434, d3freX_, 0.7064, 2.15, 0.242, 157, 153, S. AUREUS DHFR COMPLEXED WITH NADPH AND TMP
435, d3fq0A_, 0.7063, 2.40, 0.308, 160, 156, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-(3-(25-DIMETHOXYPHENYL)PROP-1-YNYL)-6-ETHYLPYRIMIDINE (UCP120B)
436, d4tu5X_, 0.7062, 2.34, 0.297, 159, 155, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3S)-3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1062)
437, d4q6aA_, 0.7062, 2.35, 0.297, 159, 155, STAPHYLOCOCCUS AUREUS V31L F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH
438, d3srwX_, 0.7061, 2.41, 0.292, 157, 154, S. AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NOVEL 7-ARYL-24- DIAMINOQUINAZOLINES
439, d1re7A_, 0.7061, 2.38, 0.286, 158, 154, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE
440, d5isqX_, 0.7060, 2.38, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS H30N F98Y DIHYDROFOLATE REDUCTASE MUTANT COMPLEXED WITH BETA-NADPH AND 3 -(3-(24-DIAMINO-6-ETHYLPYRIMIDIN-5- YL)PROP-2-YN-1-YL)-4 -METHOXY-[11 -BIPHENYL]-4-CARBOXYLIC ACID (UCP1106)
441, d4m7vA1, 0.7060, 2.43, 0.306, 160, 157, DIHYDROFOLATE REDUCTASE FROM ENTEROCOCCUS FAECALIS COMPLEXED WITH NADP(H)AND RAB-PROPYL
442, d3sr5X_, 0.7060, 2.94, 0.277, 159, 159, S. AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NOVEL 7-ARYL-24- DIAMINOQUINAZOLINES
443, d3f0bX_, 0.7059, 2.37, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-5-PHENYLPHENYL)BUT-1-YNYL]-6- METHYLPYRIMIDINE
444, d5ecxA_, 0.7058, 2.38, 0.286, 157, 154, KLEBSIELLA PNEUMONIAE DFRA1 COMPLEXED WITH NADPH AND 6-ETHYL-5-(3-(6- (PYRIDIN-4-YL)BENZO[D][13]DIOXOL-4-YL)BUT-1-YN-1-YL)PYRIMIDINE-24- DIAMINE
445, d3fywX_, 0.7058, 2.38, 0.286, 157, 154, STAPH. AUREUS DHFR COMPLEXED WITH NADPH AND AR-101
446, d3f0qX_, 0.7058, 2.94, 0.277, 159, 159, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-5-(26-DIMETHYLPHENYL)PHENYL)BUT-1-YNYL]- 6-METHYLPYRIMIDINE
447, d4lahX_, 0.7057, 2.37, 0.286, 157, 154, STRUCTURE-BASED DESIGN OF NEW DIHYDROFOLATE REDUCTASE ANTIBACTERIAL AGENTS: 7-(BENZIMIDAZOL-1-YL)-24-DIAMINOQUINAZOLINES
448, d2w9gA_, 0.7057, 2.37, 0.286, 157, 154, WILD-TYPE STAPHYLOCOCCUS AUREUS DHFR IN COMPLEX WITH NADPH AND TRIMETHOPRIM
449, d4qlgA_, 0.7055, 2.37, 0.286, 157, 154, CRYSTAL STRUCTURE OF I14V DHFR MUTANT COMPLEXED WITH FOLATE AND NADP+
450, d4q67A_, 0.7055, 2.37, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH
451, d3sruX_, 0.7055, 2.40, 0.286, 157, 154, S. AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NOVEL 7-ARYL-24- DIAMINOQUINAZOLINES
452, d3i8aX_, 0.7055, 2.39, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS H30N F98Y DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-(3-(25-DIMETHOXYPHENYL)PROP-1-YNYL)-6- ETHYLPYRIMIDINE (UCP120B)
453, d3f0uX_, 0.7055, 2.38, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-5-PHENYLPHENYL)BUT-1- YNYL]-6-METHYLPYRIMIDINE
454, d4klxB1, 0.7054, 2.38, 0.303, 159, 155, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN AN OPEN CONFORMATION.
455, d3frbX_, 0.7052, 2.38, 0.292, 157, 154, S. AUREUS F98Y DHFR COMPLEXED WITH TMP
456, d5jg0X_, 0.7051, 2.50, 0.288, 163, 156, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA- NADPH AND UCP1191
457, d5hf0X_, 0.7051, 2.50, 0.288, 163, 156, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA- NADPH CYCLIC ALPHA-NADPH ANOMER AND 3 -(3-(24-DIAMINO-6- ETHYLPYRIMIDIN-5-YL)PROP-2-YN-1-YL)-4 -METHOXY-[11 -BIPHENYL]-4- CARBOXYLIC ACID (UCP1106)
458, d4pthA_, 0.7051, 2.38, 0.286, 157, 154, ENSEMBLE MODEL FOR ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE AT 100K
459, d3srqX_, 0.7051, 2.42, 0.286, 157, 154, S. AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NOVEL 7-ARYL-24- DIAMINOQUINAZOLINES
460, d5istX_, 0.7050, 2.44, 0.282, 157, 156, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA- NADPH CYCLIC ALPHA-NADPH ANOMER AND 3 -(3-(24-DIAMINO-6- ETHYLPYRIMIDIN-5-YL)PROP-2-YN-1-YL)-4 -METHOXY-[11 -BIPHENYL]-4- CARBOXYLIC ACID (UCP1106)
461, d1rd7A_, 0.7050, 2.39, 0.286, 158, 154, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE
462, d5eccA_, 0.7048, 2.42, 0.286, 157, 154, KLEBSIELLA PNEUMONIAE DFRA1 COMPLEXED WITH NADPH AND 6-ETHYL-5-(3-(2- METHOXY-5-(PYRIDIN-4-YL)PHENYL)PROP-1-YN-1-YL)PYRIMIDINE-24-DIAMINE
463, d3m08A1, 0.7048, 2.39, 0.286, 157, 154, WILD TYPE DIHYDROFOLATE REDUCTASE FROM STAPHYLOCOCCUS AUREUS WITH INHIBITOR RAB1
464, d1re7B_, 0.7048, 2.40, 0.286, 157, 154, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE
465, d4klxA1, 0.7046, 2.27, 0.297, 159, 155, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN AN OPEN CONFORMATION.
466, d3sgyB_, 0.7046, 2.39, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3S)-3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1006)
467, d5ispX_, 0.7045, 2.38, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS F98Y DIHYDROFOLATE REDUCTASE MUTANT COMPLEXED WITH BETA-NADPH AND 3 -(3-(24-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)PROP-2- YN-1-YL)-4 -METHOXY-[11 -BIPHENYL]-4-CARBOXYLIC ACID (UCP1106)
468, d3m09A1, 0.7045, 2.39, 0.292, 157, 154, F98Y TMP-RESISTANT DIHYDROFOLATE REDUCTASE FROM STAPHYLOCOCCUS AUREUS WITH INHIBITOR RAB1
469, d3fqfA_, 0.7045, 2.42, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(345-TRIMETHOXYPHENYL)PENT-1-YNYL]- 6-METHYLPYRIMIDINE (UCP115A)
470, d3f0xX_, 0.7045, 2.92, 0.277, 159, 159, STAPHYLOCOCCUS AUREUS F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-5-(35-DIMETHYLPHENYL) PHENYL)BUT-1-YNYL]-6-METHYLPYRIMIDINE
471, d1dyiB_, 0.7045, 2.38, 0.292, 157, 154, ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 5- DEAZAFOLATE AND 510-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS
472, d3sgyA_, 0.7044, 2.41, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3S)-3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1006)
473, d3f0sX_, 0.7044, 2.40, 0.286, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-5-(35-DIMETHYLPHENYL)PHENYL)BUT-1-YNYL]- 6-METHYLPYRIMIDINE
474, d4qleA_, 0.7043, 2.34, 0.310, 158, 155, CRYSTAL STRUCTURE OF I14A DHFR MUTANT COMPLEXED WITH FOLATE AND NADP+
475, d1ra8A_, 0.7043, 2.40, 0.286, 157, 154, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 2- MONOPHOSPHOADENOSINE 5 -DIPHOSPHORIBOSE
476, d2w9hA_, 0.7042, 2.39, 0.286, 157, 154, WILD-TYPE STAPHYLOCOCCUS AUREUS DHFR IN COMPLEX WITH TRIMETHOPRIM
477, p6e4eA_, 0.7041, 2.39, 0.303, 159, 155, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM STAPHYLOCOCCUS AUREUS MW2 BOUND TO NADP AND P218 
478, d2w9sB_, 0.7041, 2.45, 0.282, 157, 156, STAPHYLOCOCCUS AUREUS S1:DHFR IN COMPLEX WITH TRIMETHOPRIM
479, d2w9sA_, 0.7041, 2.45, 0.282, 157, 156, STAPHYLOCOCCUS AUREUS S1:DHFR IN COMPLEX WITH TRIMETHOPRIM
480, d4x5fB1, 0.7040, 2.42, 0.286, 157, 154, ECDHFR COMPLEXED WITH FOLATE AND NADP+ AT 0.1 MPA
481, d2w9sC_, 0.7040, 2.46, 0.301, 159, 156, STAPHYLOCOCCUS AUREUS S1:DHFR IN COMPLEX WITH TRIMETHOPRIM
482, d2hm9A_, 0.7039, 2.99, 0.270, 159, 159, SOLUTION STRUCTURE OF DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETHOPRIM 33 STRUCTURES
483, d1dyjB_, 0.7037, 2.33, 0.301, 157, 153, ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 5- DEAZAFOLATE AND 510-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS
484, d5hf2X_, 0.7036, 2.40, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH CYCLIZED ALPHA-NADPH ANOMER AND 3 -(3-(24-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)PROP- 2-YN-1-YL)-5 -METHOXY-[11 -BIPHENYL]-4-CARBOXYLIC ACID (UCP1175)
485, d3fqoA_, 0.7034, 2.42, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(25-DIMETHOXYPHENYL)PROP-1-YNYL]-6- ETHYLPYRIMIDINE (UCP120B)
486, d4xecX_, 0.7033, 2.44, 0.292, 157, 154, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3R)-3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1061)
487, d4kjjA_, 0.7033, 2.43, 0.292, 157, 154, CRYOGENIC WT DHFR
488, d3fqzA_, 0.7033, 2.41, 0.308, 159, 156, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-4-PHENYLPHENYL)BUT-1-YNYL]-6- METHYLPYRIMIDINE
489, d1ra2A_, 0.7033, 2.34, 0.301, 157, 153, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
490, d1dyhB_, 0.7032, 2.43, 0.286, 157, 154, ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 5- DEAZAFOLATE AND 510-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS
491, d5uioC_, 0.7028, 2.30, 0.297, 159, 155, STRUCTURE OF DHFR WITH BOUND DAP P-ABG AND NADP
492, p6ddsB_, 0.7027, 2.46, 0.301, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 4-[3-[3-[2;4-BIS(AZANYL)-6-ETHYL-PYRIMIDIN-5-YL]PROP- 2-YNYL]-5-METHOXY-PHENYL]BENZOIC ACID 
493, p6ddsA_, 0.7026, 2.42, 0.286, 157, 154, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 4-[3-[3-[2;4-BIS(AZANYL)-6-ETHYL-PYRIMIDIN-5-YL]PROP- 2-YNYL]-5-METHOXY-PHENYL]BENZOIC ACID 
494, d3fqvA_, 0.7026, 2.50, 0.284, 159, 155, STAPHYLOCOCCUS AUREUS F98Y MUTANT DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 24-DIAMINO-5-[3-(3-METHOXY-4-PHENYLPHENYL)BUT-1- YNYL]-6-METHYLPYRIMIDINE
495, d4x5gB1, 0.7025, 2.44, 0.286, 157, 154, ECDHFR COMPLEXED WITH FOLATE AND NADP+ AT 270 MPA
496, p6ddsC_, 0.7024, 2.44, 0.286, 157, 154, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 4-[3-[3-[2;4-BIS(AZANYL)-6-ETHYL-PYRIMIDIN-5-YL]PROP- 2-YNYL]-5-METHOXY-PHENYL]BENZOIC ACID 
497, d1ra3A_, 0.7024, 2.31, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
498, d4x5fA_, 0.7023, 2.44, 0.286, 157, 154, ECDHFR COMPLEXED WITH FOLATE AND NADP+ AT 0.1 MPA
499, d1rb2B_, 0.7023, 2.52, 0.269, 162, 156, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
500, d3frdX_, 0.7022, 2.43, 0.308, 159, 156, S. AUREUS DHFR COMPLEXED WITH NADPH AND FOLATE
501, d2drcB_, 0.7022, 2.44, 0.286, 157, 154, INVESTIGATION OF THE FUNCTIONAL ROLE OF TRYPTOPHAN-22 IN ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE BY SITE-DIRECTED MUTAGENESIS
502, d3fl8H1, 0.7021, 2.43, 0.292, 157, 154, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH RAB1 A TMP-DIHYDROPHTHALAZINE DERIVATIVE
503, d4fhbA_, 0.7020, 2.44, 0.286, 157, 154, ENHANCING DHFR CATALYSIS BY BINDING OF AN ALLOSTERIC REGULATOR NANOBODY (NB179)
504, d1rb2A_, 0.7020, 2.04, 0.298, 153, 151, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
505, d1dhiB_, 0.7020, 2.46, 0.286, 157, 154, LONG-RANGE STRUCTURAL EFFECTS IN A SECOND-SITE REVERTANT OF A MUTANT DIHYDROFOLATE REDUCTASE
506, d1ra9A_, 0.7018, 2.32, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
507, d1ddsB_, 0.7015, 2.33, 0.303, 159, 155, MOLECULE: DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH METHOTREXATE
508, d3drcB_, 0.7013, 2.46, 0.306, 160, 157, INVESTIGATION OF THE FUNCTIONAL ROLE OF TRYPTOPHAN-22 IN ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE BY SITE-DIRECTED MUTAGENESIS
509, p6ddsD_, 0.7012, 2.77, 0.280, 159, 157, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 4-[3-[3-[2;4-BIS(AZANYL)-6-ETHYL-PYRIMIDIN-5-YL]PROP- 2-YNYL]-5-METHOXY-PHENYL]BENZOIC ACID 
510, d1ra1A_, 0.7011, 2.77, 0.280, 159, 157, DIHYDROFOLATE REDUCTASE COMPLEXED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM)
511, d4kl9A1, 0.7010, 2.44, 0.292, 157, 154, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS IN THE SPACE GROUP C2
512, d5eajB_, 0.7009, 2.31, 0.303, 159, 155, CRYSTAL STRUCTURE OF DHFR IN 0% ISOPROPANOL
513, d4dfrB_, 0.7009, 2.77, 0.280, 159, 157, CRYSTAL STRUCTURES OF ESCHERICHIA COLI AND LACTOBACILLUS CASEI DIHYDROFOLATE REDUCTASE REFINED AT 1.7 ANGSTROMS RESOLUTION. I. GENERAL FEATURES AND BINDING OF METHOTREXATE
514, d1rd7B_, 0.7009, 2.48, 0.301, 159, 156, DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE
515, d4kjlA_, 0.7007, 2.34, 0.303, 159, 155, ROOM TEMPERATURE N23PPS148A DHFR
516, d1draB_, 0.7007, 2.42, 0.308, 159, 156, CRYSTAL STRUCTURE OF UNLIGANDED ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. LIGAND-INDUCED CONFORMATIONAL CHANGES AND COOPERATIVITY IN BINDING
517, d4x5gA_, 0.7006, 2.43, 0.286, 157, 154, ECDHFR COMPLEXED WITH FOLATE AND NADP+ AT 270 MPA
518, d1jolB_, 0.7006, 2.44, 0.301, 159, 156, THE CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN FOLINIC ACID (LEUCOVORIN) AND E. COLI DIHYDROFOLATE REDUCTASE
519, d1dg5A_, 0.7006, 1.93, 0.360, 153, 150, DIHYDROFOLATE REDUCTASE OF MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH NADPH AND TRIMETHOPRIM
520, d1ddrB_, 0.7004, 2.31, 0.303, 159, 155, MOLECULE: DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH METHOTREXATE AND UREA
521, d4x5jA_, 0.7003, 2.34, 0.303, 159, 155, ECDHFR COMPLEXED WITH FOLATE AND NADP+ AT 750 MPA
522, d4x5iA_, 0.7002, 2.45, 0.308, 159, 156, ECDHFR COMPLEXED WITH FOLATE AND NADP+ AT 660 MPA
523, d4x5hA_, 0.7002, 2.34, 0.303, 159, 155, ECDHFR COMPLEXED WITH FOLATE AND NADP+ AT 500 MPA
524, d1tdrB_, 0.7002, 2.46, 0.308, 159, 156, EXPRESSION CHARACTERIZATION AND CRYSTALLOGRAPHIC ANALYSIS OF TELLUROMETHIONYL DIHYDROFOLATE REDUCTASE
525, d4kjkA_, 0.7001, 2.45, 0.308, 159, 156, ROOM TEMPERATURE WT DHFR
526, d1d1gB_, 0.7001, 2.65, 0.282, 159, 156, DIHYDROFOLATE REDUCTASE FROM THERMOTOGA MARITIMA
527, d1dg7A_, 0.7000, 2.35, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE OF MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH NADPH AND 4-BROMO WR99210
528, d3fl9B_, 0.6998, 2.70, 0.282, 159, 156, CRYSTAL STRUCTURE OF B. ANTHRACIS DIHYDROFOLATE REDUCTASE (DHFR) WITH TRIMETHOPRIM
529, d1d1gA_, 0.6998, 2.46, 0.308, 159, 156, DIHYDROFOLATE REDUCTASE FROM THERMOTOGA MARITIMA
530, p6ddpA_, 0.6996, 2.46, 0.308, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 3 -[(2R)-4-(2;4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)BUT-3- YN-2-YL]-5 -METHOXY[1;1 -BIPHENYL]-4-CARBOXYLIC ACID 
531, d1rb3B_, 0.6996, 2.36, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
532, d1drbB_, 0.6995, 2.08, 0.318, 157, 151, CRYSTAL STRUCTURE OF UNLIGANDED ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. LIGAND-INDUCED CONFORMATIONAL CHANGES AND COOPERATIVITY IN BINDING
533, p5ujxB_, 0.6994, 2.47, 0.314, 159, 156, CRYSTAL STRUCTURE OF DHFR IN 20% ISOPROPANOL
534, d5uioE_, 0.6994, 2.34, 0.303, 159, 155, STRUCTURE OF DHFR WITH BOUND DAP P-ABG AND NADP
535, d5e8qB_, 0.6994, 2.36, 0.303, 159, 155, CRYSTAL STRUCTURE OF DHFR IN 20% ISOPROPANOL
536, p6ddpC_, 0.6993, 2.58, 0.284, 159, 155, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 3 -[(2R)-4-(2;4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)BUT-3- YN-2-YL]-5 -METHOXY[1;1 -BIPHENYL]-4-CARBOXYLIC ACID 
537, d1rf7A_, 0.6990, 2.50, 0.301, 159, 156, STRUCTURE OF DIHYDROFOLATE REDUCTASE COMPLEXED WITH DIHYDROFOLATE
538, d1dhjB_, 0.6990, 2.47, 0.301, 159, 156, LONG-RANGE STRUCTURAL EFFECTS IN A SECOND-SITE REVERTANT OF A MUTANT DIHYDROFOLATE REDUCTASE
539, p6ddwA_, 0.6989, 2.47, 0.301, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND N-(4-{[(2-AMINO-4-OXO-3;4-DIHYDROPTERIDIN-6-YL) METHYL]AMINO}-2-HYDROXYBENZENE-1-CARBONYL)-L-GLUTAMIC ACID 
540, d1dg8A_, 0.6988, 2.47, 0.301, 159, 156, DIHYDROFOLATE REDUCTASE OF MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH NADPH
541, p6ddpB_, 0.6987, 2.47, 0.308, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 3 -[(2R)-4-(2;4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)BUT-3- YN-2-YL]-5 -METHOXY[1;1 -BIPHENYL]-4-CARBOXYLIC ACID 
542, d4xe6X1, 0.6987, 2.21, 0.309, 156, 152, STAPHYLOCOCCUS AUREUS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 6-ETHYL-5-[(3R)-3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL]BUT-1-YN-1- YL]PYRIMIDINE-24-DIAMINE (UCP1061)
543, d2cigA_, 0.6987, 2.73, 0.220, 164, 159, DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TUBERCULOSIS INHIBITED BY THE ACYCLIC 4R ISOMER OF INH-NADP A DERIVATIVE OF THE PRODRUG ISONIAZID.
544, d1df7A_, 0.6987, 2.58, 0.284, 159, 155, DIHYDROFOLATE REDUCTASE OF MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH NADPH AND METHOTREXATE
545, d4i1nA_, 0.6985, 2.52, 0.355, 158, 155, R104A-CA1697 NANOBODY BINDING TO THE BINARY DHFR.FOLATE COMPLEX
546, d3ochB_, 0.6985, 2.75, 0.220, 164, 159, CHEMICALLY SELF-ASSEMBLED ANTIBODY NANORINGS (CSANS): DESIGN AND CHARACTERIZATION OF AN ANTI-CD3 IGM BIOMIMETIC
547, p6ddpD_, 0.6982, 2.69, 0.282, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA-NADPH AND 3 -[(2R)-4-(2;4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)BUT-3- YN-2-YL]-5 -METHOXY[1;1 -BIPHENYL]-4-CARBOXYLIC ACID 
548, d2w9sF_, 0.6981, 2.46, 0.308, 159, 156, STAPHYLOCOCCUS AUREUS S1:DHFR IN COMPLEX WITH TRIMETHOPRIM
549, d2w9sD_, 0.6979, 2.47, 0.308, 159, 156, STAPHYLOCOCCUS AUREUS S1:DHFR IN COMPLEX WITH TRIMETHOPRIM
550, d2inqB_, 0.6977, 2.48, 0.308, 159, 156, NEUTRON CRYSTAL STRUCTURE OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE BOUND TO THE ANTI-CANCER DRUG METHOTREXATE
551, d1rb3A_, 0.6977, 2.48, 0.301, 160, 156, DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
552, p5uiiA_, 0.6976, 2.48, 0.308, 159, 156, STRUCTURE OF DHFR WITH BOUND BUFORMIN AND NADP
553, d1rc4A_, 0.6975, 2.69, 0.282, 159, 156, DIHYDROFOLATE REDUCTASE COMPLEXED WITH 510- DIDEAZATETRAHYDROFOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (OXIDIZED FORM)
554, d1cz3A_, 0.6975, 2.49, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE FROM THERMOTOGA MARITIMA
555, d5ja3C_, 0.6973, 2.41, 0.303, 159, 155, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA- NADPH AND 3 -(3-(24-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)PROP-2-YN-1- YL)-4 -METHOXY-[11 -B IPHENYL]-4-CARBOXYLIC ACID (UCP1106)
556, d2w9sE_, 0.6973, 2.69, 0.282, 159, 156, STAPHYLOCOCCUS AUREUS S1:DHFR IN COMPLEX WITH TRIMETHOPRIM
557, d1rx6A_, 0.6973, 2.59, 0.284, 159, 155, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH 510- DIDEAZATETRAHYDROFOLATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE (REDUCED FORM)
558, d1rx4A_, 0.6972, 2.69, 0.282, 159, 156, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH 510- DIDEAZATETRAHYDROFOLATE AND 2 -MONOPHOSPHOADENOSINE 5 - DIPHOSPHORIBOSE
559, d5uioB_, 0.6969, 2.44, 0.281, 156, 153, STRUCTURE OF DHFR WITH BOUND DAP P-ABG AND NADP
560, d5ja3B_, 0.6966, 2.60, 0.277, 159, 155, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA- NADPH AND 3 -(3-(24-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)PROP-2-YN-1- YL)-4 -METHOXY-[11 -B IPHENYL]-4-CARBOXYLIC ACID (UCP1106)
561, d1rx7A_, 0.6966, 2.57, 0.284, 159, 155, STRUCTURE OF DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE
562, d5ja3D_, 0.6965, 2.47, 0.303, 159, 155, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA- NADPH AND 3 -(3-(24-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)PROP-2-YN-1- YL)-4 -METHOXY-[11 -B IPHENYL]-4-CARBOXYLIC ACID (UCP1106)
563, d1dyiA_, 0.6963, 2.49, 0.308, 159, 156, ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 5- DEAZAFOLATE AND 510-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS
564, d5ja3A_, 0.6960, 2.70, 0.282, 159, 156, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH BETA- NADPH AND 3 -(3-(24-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)PROP-2-YN-1- YL)-4 -METHOXY-[11 -B IPHENYL]-4-CARBOXYLIC ACID (UCP1106)
565, d4i13A_, 0.6960, 2.40, 0.288, 157, 153, NANOBODY CA1697 BINDING TO THE DHFR.FOLATE BINARY COMPLEX
566, d1rx5A_, 0.6960, 2.40, 0.288, 157, 153, DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH 510- DIDEAZATETRAHYDROFOLATE
567, d4qleB_, 0.6959, 2.47, 0.308, 159, 156, CRYSTAL STRUCTURE OF I14A DHFR MUTANT COMPLEXED WITH FOLATE AND NADP+
568, d1cz3B_, 0.6957, 2.40, 0.303, 159, 155, DIHYDROFOLATE REDUCTASE FROM THERMOTOGA MARITIMA
569, d4m2xG_, 0.6948, 2.39, 0.303, 159, 155, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETREXATE (TMQ)
570, d4ej1B_, 0.6946, 2.49, 0.303, 159, 155, BINDING OF NB113 CAMELID ANTIBODY FRAGMENT WITH THE BINARY DHFR:FOLATE COMPLEX
571, d4eizB_, 0.6946, 2.76, 0.226, 164, 159, STRUCTURE OF NB113 BOUND TO APODHFR
572, d1dyhA_, 0.6946, 2.74, 0.276, 159, 156, ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 5- DEAZAFOLATE AND 510-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS
573, d5cccA_, 0.6945, 2.41, 0.288, 157, 153, WILD-TYPE E.COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH 510- DIDEAZATETRAHYDROFOLATE AND OXIDIZED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE
574, d5uipA1, 0.6940, 2.46, 0.305, 159, 154, STRUCTURE OF DHFR WITH BOUND DAP P-ABG AND NADP
575, d4eigA_, 0.6940, 2.46, 0.305, 159, 154, CA1698 CAMEL ANTIBODY FRAGMENT IN COMPLEX WITH DHFR
576, d1dyjA_, 0.6937, 2.43, 0.301, 160, 156, ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE 5- DEAZAFOLATE AND 510-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS
577, d2drcA_, 0.6936, 2.76, 0.282, 159, 156, INVESTIGATION OF THE FUNCTIONAL ROLE OF TRYPTOPHAN-22 IN ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE BY SITE-DIRECTED MUTAGENESIS
578, d5eajA_, 0.6935, 2.44, 0.305, 159, 154, CRYSTAL STRUCTURE OF DHFR IN 0% ISOPROPANOL
579, d4eizA_, 0.6934, 2.61, 0.277, 159, 155, STRUCTURE OF NB113 BOUND TO APODHFR
580, d4ej1A_, 0.6933, 2.58, 0.301, 159, 156, BINDING OF NB113 CAMELID ANTIBODY FRAGMENT WITH THE BINARY DHFR:FOLATE COMPLEX
581, d1tdrA_, 0.6932, 2.63, 0.277, 159, 155, EXPRESSION CHARACTERIZATION AND CRYSTALLOGRAPHIC ANALYSIS OF TELLUROMETHIONYL DIHYDROFOLATE REDUCTASE
582, p5ujxA_, 0.6930, 2.50, 0.303, 159, 155, CRYSTAL STRUCTURE OF DHFR IN 20% ISOPROPANOL
583, d1jomA_, 0.6929, 2.47, 0.305, 159, 154, THE CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN FOLINIC ACID (LEUCOVORIN) AND E. COLI DIHYDROFOLATE REDUCTASE
584, d5e8qA_, 0.6927, 2.40, 0.297, 159, 155, CRYSTAL STRUCTURE OF DHFR IN 20% ISOPROPANOL
585, d5cc9A_, 0.6926, 2.76, 0.220, 168, 159, L28F E.COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH 510- DIDEAZATETRAHYDROFOLATE AND OXIDIZED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE
586, d4qlgB_, 0.6923, 2.76, 0.220, 168, 159, CRYSTAL STRUCTURE OF I14V DHFR MUTANT COMPLEXED WITH FOLATE AND NADP+
587, d4dfrA_, 0.6923, 2.63, 0.277, 159, 155, CRYSTAL STRUCTURES OF ESCHERICHIA COLI AND LACTOBACILLUS CASEI DIHYDROFOLATE REDUCTASE REFINED AT 1.7 ANGSTROMS RESOLUTION. I. GENERAL FEATURES AND BINDING OF METHOTREXATE
588, d1draA_, 0.6921, 2.51, 0.305, 159, 154, CRYSTAL STRUCTURE OF UNLIGANDED ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. LIGAND-INDUCED CONFORMATIONAL CHANGES AND COOPERATIVITY IN BINDING
589, d4m2xC_, 0.6919, 2.56, 0.303, 159, 155, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETREXATE (TMQ)
590, d1jolA_, 0.6919, 2.45, 0.303, 159, 155, THE CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN FOLINIC ACID (LEUCOVORIN) AND E. COLI DIHYDROFOLATE REDUCTASE
591, d5uipB1, 0.6918, 2.51, 0.303, 159, 155, STRUCTURE OF DHFR WITH BOUND DAP P-ABG AND NADP
592, d3drcA_, 0.6917, 2.52, 0.303, 158, 155, INVESTIGATION OF THE FUNCTIONAL ROLE OF TRYPTOPHAN-22 IN ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE BY SITE-DIRECTED MUTAGENESIS
593, d1dhiA_, 0.6914, 2.62, 0.310, 159, 155, LONG-RANGE STRUCTURAL EFFECTS IN A SECOND-SITE REVERTANT OF A MUTANT DIHYDROFOLATE REDUCTASE
594, d1dhjA_, 0.6911, 2.46, 0.303, 159, 155, LONG-RANGE STRUCTURAL EFFECTS IN A SECOND-SITE REVERTANT OF A MUTANT DIHYDROFOLATE REDUCTASE
595, d5dfrA_, 0.6910, 2.47, 0.297, 159, 155, CRYSTAL STRUCTURE OF UNLIGANDED ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. LIGAND-INDUCED CONFORMATIONAL CHANGES AND COOPERATIVITY IN BINDING
596, d3ochA_, 0.6909, 2.40, 0.299, 159, 154, CHEMICALLY SELF-ASSEMBLED ANTIBODY NANORINGS (CSANS): DESIGN AND CHARACTERIZATION OF AN ANTI-CD3 IGM BIOMIMETIC
597, d1vdrB_, 0.6908, 2.70, 0.301, 159, 156, DIHYDROFOLATE REDUCTASE
598, d1drbA_, 0.6908, 2.67, 0.308, 159, 156, CRYSTAL STRUCTURE OF UNLIGANDED ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. LIGAND-INDUCED CONFORMATIONAL CHANGES AND COOPERATIVITY IN BINDING
599, d1ddsA_, 0.6902, 2.46, 0.303, 159, 155, MOLECULE: DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH METHOTREXATE
600, d4m2xA_, 0.6900, 2.40, 0.299, 159, 154, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETREXATE (TMQ)
601, d5u26A1, 0.6891, 2.38, 0.307, 159, 153, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE BOUND TO NADP AND P218 INHIBITOR
602, d4m2xE_, 0.6887, 2.41, 0.299, 159, 154, MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE COMPLEXED WITH TRIMETREXATE (TMQ)
603, d3tq9A_, 0.6881, 2.54, 0.310, 159, 155, STRUCTURE OF THE DIHYDROFOLATE REDUCTASE (FOLA) FROM COXIELLA BURNETII IN COMPLEX WITH METHOTREXATE
604, p3dl6D1, 0.6881, 2.40, 0.292, 159, 154, CRYSTAL STRUCTURE OF THE A287F/S290G ACTIVE SITE MUTANT OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS
605, d1rg7A_, 0.6880, 2.57, 0.308, 159, 156, DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE
606, d3k74A_, 0.6879, 2.42, 0.305, 159, 154, DISRUPTION OF PROTEIN DYNAMICS BY AN ALLOSTERIC EFFECTOR ANTIBODY
607, d5u27A1, 0.6878, 2.75, 0.282, 159, 156, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE BOUND TO NADP AND P65 INHIBITOR
608, d1ddrA_, 0.6878, 2.49, 0.303, 159, 155, MOLECULE: DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH METHOTREXATE AND UREA
609, p3dl6E1, 0.6877, 2.39, 0.305, 158, 154, CRYSTAL STRUCTURE OF THE A287F/S290G ACTIVE SITE MUTANT OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS
610, p3dl6C1, 0.6875, 2.49, 0.303, 159, 155, CRYSTAL STRUCTURE OF THE A287F/S290G ACTIVE SITE MUTANT OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS
611, p4q0dE1, 0.6869, 2.49, 0.303, 159, 155, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP METHOTREXATE AND 2-AMINO-4-OXO-47-DIHYDRO- PYRROLO[23-D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
612, p4q0dC1, 0.6868, 2.50, 0.303, 159, 155, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP METHOTREXATE AND 2-AMINO-4-OXO-47-DIHYDRO- PYRROLO[23-D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
613, p4q0dB1, 0.6868, 2.26, 0.307, 154, 150, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP METHOTREXATE AND 2-AMINO-4-OXO-47-DIHYDRO- PYRROLO[23-D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
614, p4q0dA1, 0.6868, 2.54, 0.303, 159, 155, CRYSTAL STRUCTURE OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS IN COMPLEX WITH NADPH FDUMP METHOTREXATE AND 2-AMINO-4-OXO-47-DIHYDRO- PYRROLO[23-D]PYRIMIDINE-METHYL-PHENYL-L-GLUTAMIC ACID.
615, d3tqbA_, 0.6856, 2.17, 0.233, 154, 150, STRUCTURE OF THE DIHYDROFOLATE REDUCTASE (FOLA) FROM COXIELLA BURNETII IN COMPLEX WITH FOLATE
616, d2inqA_, 0.6851, 2.44, 0.299, 159, 154, NEUTRON CRYSTAL STRUCTURE OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE BOUND TO THE ANTI-CANCER DRUG METHOTREXATE
617, d6dfrA_, 0.6846, 2.45, 0.299, 159, 154, CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE. THE NADP+ HOLOENZYME AND THE FOLATE(DOT)NADP+ TERNARY COMPLEX. SUBSTRATE BINDING AND A MODEL FOR THE TRANSITION STATE
618, p6cxmB_, 0.6837, 2.71, 0.277, 159, 155, CRYSTAL STRUCTURE OF A DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM SMEGMATIS IN COMPLEX WITH NADP AND P218 
619, d2hqpA_, 0.6836, 2.59, 0.279, 159, 154, SOLUTION STRUCTURE OF L.CASEI DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH 32 STRUCTURES
620, d5uihA_, 0.6815, 2.83, 0.282, 159, 156, STRUCTURE OF DHFR WITH BOUND PHENFORMIN AND NADP
621, p6cxmA_, 0.6809, 2.39, 0.273, 151, 150, CRYSTAL STRUCTURE OF A DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM SMEGMATIS IN COMPLEX WITH NADP AND P218 
622, d5ujfA1, 0.6792, 2.06, 0.327, 150, 147, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS DIHYDROFOLATE REDUCTASE BOUND P218 INHIBITOR
623, d4pstA_, 0.6790, 2.62, 0.303, 159, 155, MULTICONFORMER MODEL FOR ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE AT 277 K
624, d3zpcA2, 0.6777, 2.74, 0.308, 159, 156, ACINETOBACTER BAUMANNII RIBD FORM 1
625, d3zpcB2, 0.6773, 2.73, 0.284, 159, 155, ACINETOBACTER BAUMANNII RIBD FORM 1
626, d2l28A_, 0.6771, 2.52, 0.303, 159, 155, SOLUTION STRUCTURE OF LACTOBACILLUS CASEI DIHYDROFOLATE REDUCTASE APO- FORM 25 CONFORMERS
627, d2w9tA_, 0.6769, 2.05, 0.327, 150, 147, STAPHYLOCOCCUS AUREUS S1:DHFR
628, d2jybA_, 0.6764, 2.05, 0.327, 150, 147, BINARY HVDHFR1:FOLATE COMPLEX
629, d2w9tB_, 0.6761, 2.03, 0.327, 150, 147, STAPHYLOCOCCUS AUREUS S1:DHFR
630, d1juvA_, 0.6755, 2.03, 0.327, 150, 147, CRYSTAL STRUCTURE ANALYSIS OF DIHYDROFOLATE REDUCTASE FROM BACTERIOPHAGE T4
631, d3zpgA2, 0.6730, 2.03, 0.327, 150, 147, ACINETOBACTER BAUMANNII RIBD FORM 2
632, d5hi6A1, 0.6717, 2.03, 0.327, 150, 147, THE HIGH RESOLUTION STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM YERSINIA PESTIS COMPLEX WITH METHOTREXATE AS CLOSED FORM
633, d2d5nB1, 0.6694, 2.41, 0.273, 151, 150, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
634, d2b3zC1, 0.6689, 2.50, 0.305, 158, 154, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
635, d4g3mC2, 0.6688, 2.29, 0.313, 154, 150, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG: THE DEAMINATION PROCESS IN RIBOFLAVIN BIOSYNTHESIS
636, d4g3mB2, 0.6685, 2.90, 0.266, 155, 154, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG: THE DEAMINATION PROCESS IN RIBOFLAVIN BIOSYNTHESIS
637, d3ex8B2, 0.6684, 2.91, 0.261, 162, 157, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG REDUCTION MECHANISM IN RIBOFLAVIN BIOSYNTHESIS
638, d2b3zB1, 0.6668, 2.45, 0.289, 159, 152, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
639, d3ex8C2, 0.6663, 2.57, 0.265, 155, 151, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG REDUCTION MECHANISM IN RIBOFLAVIN BIOSYNTHESIS
640, d2d5nC1, 0.6658, 3.08, 0.280, 159, 157, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
641, d4qlfA_, 0.6649, 2.07, 0.308, 151, 146, CRYSTAL STRUCTURE OF I14G DHFR MUTANT COMPLEXED WITH FOLATE AND NADP+
642, d2b3zD1, 0.6647, 2.82, 0.134, 208, 157, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
643, d2aznA1, 0.6645, 2.82, 0.134, 208, 157, X-RAY STRUCTURE OF 25-DIAMINO-6-RIBOSYLAMINO-4(3H)-PYRIMIDINONE 5- PHOSPHATE REDUCTASE
644, d3ex8D2, 0.6639, 2.87, 0.134, 208, 157, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG REDUCTION MECHANISM IN RIBOFLAVIN BIOSYNTHESIS
645, d4g3mD2, 0.6635, 2.93, 0.266, 162, 158, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG: THE DEAMINATION PROCESS IN RIBOFLAVIN BIOSYNTHESIS
646, p4kyaD1, 0.6634, 2.91, 0.286, 159, 154, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 3 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
647, d3ex8A2, 0.6634, 2.91, 0.286, 159, 154, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG REDUCTION MECHANISM IN RIBOFLAVIN BIOSYNTHESIS
648, d2aznE_, 0.6633, 2.61, 0.227, 162, 154, X-RAY STRUCTURE OF 25-DIAMINO-6-RIBOSYLAMINO-4(3H)-PYRIMIDINONE 5- PHOSPHATE REDUCTASE
649, d2b3zA1, 0.6631, 2.92, 0.286, 159, 154, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
650, d2aznD_, 0.6628, 2.80, 0.186, 193, 156, X-RAY STRUCTURE OF 25-DIAMINO-6-RIBOSYLAMINO-4(3H)-PYRIMIDINONE 5- PHOSPHATE REDUCTASE
651, d2aznB_, 0.6627, 2.80, 0.186, 193, 156, X-RAY STRUCTURE OF 25-DIAMINO-6-RIBOSYLAMINO-4(3H)-PYRIMIDINONE 5- PHOSPHATE REDUCTASE
652, d2obcB2, 0.6624, 2.86, 0.135, 205, 156, THE CRYSTAL STRUCTURE OF RIBD FROM ESCHERICHIA COLI IN COMPLEX WITH A SUBSTRATE ANALOGUE RIBOSE 5-PHOSPHATE (BETA FORM) BOUND TO THE ACTIVE SITE OF THE REDUCTASE DOMAIN
653, d2aznC_, 0.6622, 2.48, 0.300, 153, 150, X-RAY STRUCTURE OF 25-DIAMINO-6-RIBOSYLAMINO-4(3H)-PYRIMIDINONE 5- PHOSPHATE REDUCTASE
654, d2aznF_, 0.6621, 3.02, 0.132, 214, 159, X-RAY STRUCTURE OF 25-DIAMINO-6-RIBOSYLAMINO-4(3H)-PYRIMIDINONE 5- PHOSPHATE REDUCTASE
655, d2d5nD1, 0.6620, 2.98, 0.127, 214, 157, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
656, d2d5nA1, 0.6616, 3.15, 0.119, 214, 159, CRYSTAL STRUCTURE OF A BIFUNCTIONAL DEAMINASE AND REDUCTASE INVOLVED IN RIBOFLAVIN BIOSYNTHESIS
657, d4g3mA2, 0.6615, 3.10, 0.127, 214, 158, COMPLEX STRUCTURE OF BACILLUS SUBTILIS RIBG: THE DEAMINATION PROCESS IN RIBOFLAVIN BIOSYNTHESIS
658, d2g6vB2, 0.6595, 3.00, 0.127, 214, 157, THE CRYSTAL STRUCTURE OF RIBD FROM ESCHERICHIA COLI
659, p4ky4E1, 0.6582, 3.19, 0.126, 214, 159, CRYSTAL STRUCTURE OF NON-CLASSICAL TS INHIBITOR 2 IN COMPLEX WITH TOXOPLASMA GONDII TS-DHFR
660, d2ithA_, 0.6579, 3.24, 0.118, 214, 161, NMR STRUCTURE OF HALOFERAX VOLCANII DHFR
661, d5hi6B1, 0.6561, 3.06, 0.120, 214, 158, THE HIGH RESOLUTION STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM YERSINIA PESTIS COMPLEX WITH METHOTREXATE AS CLOSED FORM
662, d2hxvA1, 0.6537, 2.72, 0.291, 157, 151, CRYSTAL STRUCTURE OF A DIAMINOHYDROXYPHOSPHORIBOSYLAMINOPYRIMIDINE DEAMINASE/ 5-AMINO-6-(5-PHOSPHORIBOSYLAMINO)URACIL REDUCTASE (TM1828) FROM THERMOTOGA MARITIMA AT 1.80 A RESOLUTION
663, p2xw7B_, 0.6532, 3.05, 0.127, 214, 157, STRUCTURE OF MYCOBACTERIUM SMEGMATIS PUTATIVE REDUCTASE MS0308
664, p3jtwA_, 0.6515, 3.05, 0.101, 214, 158, CRYSTAL STRUCTURE OF PUTATIVE DIHYDROFOLATE REDUCTASE (YP_805003.1) FROM PEDIOCOCCUS PENTOSACEUS ATCC 25745 AT 1.90 A RESOLUTION
665, d4qi9B1, 0.6514, 3.05, 0.101, 214, 158, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM YERSINIA PESTIS COMPLEXED WITH METHOTREXATE
666, p3jtwB_, 0.6510, 3.22, 0.126, 214, 159, CRYSTAL STRUCTURE OF PUTATIVE DIHYDROFOLATE REDUCTASE (YP_805003.1) FROM PEDIOCOCCUS PENTOSACEUS ATCC 25745 AT 1.90 A RESOLUTION
667, d2o7pA2, 0.6498, 3.04, 0.127, 214, 157, THE CRYSTAL STRUCTURE OF RIBD FROM ESCHERICHIA COLI IN COMPLEX WITH THE OXIDISED NADP+ COFACTOR IN THE ACTIVE SITE OF THE REDUCTASE DOMAIN
668, d2obcA2, 0.6490, 1.96, 0.343, 149, 140, THE CRYSTAL STRUCTURE OF RIBD FROM ESCHERICHIA COLI IN COMPLEX WITH A SUBSTRATE ANALOGUE RIBOSE 5-PHOSPHATE (BETA FORM) BOUND TO THE ACTIVE SITE OF THE REDUCTASE DOMAIN
669, d4qi9A1, 0.6481, 3.29, 0.124, 214, 161, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM YERSINIA PESTIS COMPLEXED WITH METHOTREXATE
670, d2g6vA2, 0.6480, 3.11, 0.101, 214, 158, THE CRYSTAL STRUCTURE OF RIBD FROM ESCHERICHIA COLI
671, p2xw7A_, 0.6439, 3.28, 0.118, 214, 161, STRUCTURE OF MYCOBACTERIUM SMEGMATIS PUTATIVE REDUCTASE MS0308
672, d2o7pB2, 0.6387, 3.12, 0.101, 214, 158, THE CRYSTAL STRUCTURE OF RIBD FROM ESCHERICHIA COLI IN COMPLEX WITH THE OXIDISED NADP+ COFACTOR IN THE ACTIVE SITE OF THE REDUCTASE DOMAIN
673, p4eilH1, 0.6340, 3.09, 0.101, 214, 158, CRYSTAL STRUCTURE OF THE LOOP TRUNCATED TOXOPLASMA GONDII TS-DHFR
674, d4qi9C1, 0.6310, 3.17, 0.094, 218, 159, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM YERSINIA PESTIS COMPLEXED WITH METHOTREXATE
675, d3q1hA1, 0.6297, 3.10, 0.101, 214, 158, CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM YERSINIA PESTIS
676, d2kgkA_, 0.6194, 3.14, 0.101, 214, 158, SOLUTION STRUCTURE OF BACILLUS ANTHRACIS DIHYDROFOLATE REDUCTASE
677, p4ha7B_, 0.6064, 3.14, 0.120, 214, 158, STRUCTURAL INSIGHTS INTO THE REDUCTION MECHANISM OF SACCHAROMYCES CEREVISIA RIBOFLAVIN BIOSYNTHESIS REDUCTASE RIB7
678, p4ha9B_, 0.6040, 3.35, 0.111, 214, 162, STRUCTURAL INSIGHTS INTO THE REDUCTION MECHANISM OF SACCHAROMYCES CEREVISIA RIBOFLAVIN BIOSYNTHESIS REDUCTASE RIB7
679, d5fdaA1, 0.6029, 3.06, 0.139, 215, 158, THE HIGH RESOLUTION STRUCTURE OF APO FORM DIHYDROFOLATE REDUCTASE FROM YERSINIA PESTIS AT 1.55 A
680, p5dxvA_, 0.5436, 3.06, 0.139, 215, 158, CRYSTAL STRUCTURE OF RETHREADED DHFR
681, p5dxvB_, 0.5427, 3.26, 0.087, 218, 160, CRYSTAL STRUCTURE OF RETHREADED DHFR
682, p2zwaA1, 0.5361, 3.26, 0.087, 218, 160, CRYSTAL STRUCTURE OF TRNA WYBUTOSINE SYNTHESIZING ENZYME TYW4
683, p2zzkB1, 0.5353, 1.93, 0.345, 148, 139, CRYSTAL STRUCTURE OF TRNA WYBUTOSINE SYNTHESIZING ENZYME TYW4
684, p2zw9A1, 0.5344, 2.79, 0.242, 162, 153, CRYSTAL STRUCTURE OF TRNA WYBUTOSINE SYNTHESIZING ENZYME TYW4
685, p2zzkA1, 0.5339, 2.79, 0.242, 162, 153, CRYSTAL STRUCTURE OF TRNA WYBUTOSINE SYNTHESIZING ENZYME TYW4
686, p2zw9B1, 0.5325, 2.53, 0.304, 153, 148, CRYSTAL STRUCTURE OF TRNA WYBUTOSINE SYNTHESIZING ENZYME TYW4
687, p2zwaB1, 0.5321, 2.75, 0.172, 196, 151, CRYSTAL STRUCTURE OF TRNA WYBUTOSINE SYNTHESIZING ENZYME TYW4
688, d4pssA_, 0.5283, 2.75, 0.172, 196, 151, MULTICONFORMER MODEL FOR ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE AT 100K
689, p4a0hA1, 0.5271, 3.41, 0.126, 174, 159, STRUCTURE OF BIFUNCTIONAL DAPA AMINOTRANSFERASE-DTB SYNTHETASE FROM ARABIDOPSIS THALIANA BOUND TO 7-KETO 8-AMINO PELARGONIC ACID (KAPA)
690, p4a0rB1, 0.5268, 3.42, 0.196, 173, 158, STRUCTURE OF BIFUNCTIONAL DAPA AMINOTRANSFERASE-DTB SYNTHETASE FROM ARABIDOPSIS THALIANA BOUND TO DETHIOBIOTIN (DTB).
691, p4a0rA1, 0.5241, 3.42, 0.196, 173, 158, STRUCTURE OF BIFUNCTIONAL DAPA AMINOTRANSFERASE-DTB SYNTHETASE FROM ARABIDOPSIS THALIANA BOUND TO DETHIOBIOTIN (DTB).
692, p4a0hB1, 0.5239, 2.20, 0.296, 147, 142, STRUCTURE OF BIFUNCTIONAL DAPA AMINOTRANSFERASE-DTB SYNTHETASE FROM ARABIDOPSIS THALIANA BOUND TO 7-KETO 8-AMINO PELARGONIC ACID (KAPA)
693, p4a0gA1, 0.5239, 3.42, 0.209, 169, 158, STRUCTURE OF BIFUNCTIONAL DAPA AMINOTRANSFERASE-DTB SYNTHETASE FROM ARABIDOPSIS THALIANA IN ITS APO FORM.
694, p4a0gB1, 0.5229, 3.33, 0.082, 211, 158, STRUCTURE OF BIFUNCTIONAL DAPA AMINOTRANSFERASE-DTB SYNTHETASE FROM ARABIDOPSIS THALIANA IN ITS APO FORM.
695, p3a8tA1, 0.5192, 3.44, 0.082, 208, 158, PLANT ADENYLATE ISOPENTENYLTRANSFERASE IN COMPLEX WITH ATP
696, p4a0fA1, 0.5190, 2.21, 0.298, 146, 141, STRUCTURE OF SELENOMETHIONINE SUBSTITUTED BIFUNCTIONAL DAPA AMINOTRANSFERASE-DETHIOBIOTIN SYNTHETASE FROM ARABIDOPSIS THALIANA IN ITS APO FORM.
697, p4a0gC1, 0.5175, 3.34, 0.083, 208, 157, STRUCTURE OF BIFUNCTIONAL DAPA AMINOTRANSFERASE-DTB SYNTHETASE FROM ARABIDOPSIS THALIANA IN ITS APO FORM.
698, p4a0fB1, 0.5147, 3.16, 0.116, 175, 155, STRUCTURE OF SELENOMETHIONINE SUBSTITUTED BIFUNCTIONAL DAPA AMINOTRANSFERASE-DETHIOBIOTIN SYNTHETASE FROM ARABIDOPSIS THALIANA IN ITS APO FORM.
699, p3r9jB_, 0.5143, 3.16, 0.116, 175, 155, 4.3A RESOLUTION STRUCTURE OF A MIND-MINE(I24N) PROTEIN COMPLEX
700, p3r9jA_, 0.5135, 3.19, 0.085, 211, 153, 4.3A RESOLUTION STRUCTURE OF A MIND-MINE(I24N) PROTEIN COMPLEX
701, d1mezA_, 0.5130, 2.29, 0.368, 147, 136, STRUCTURE OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE COMPLEXED WITH SAMP GDP SO4(2-) AND MG(2+)
702, d1lonA_, 0.5129, 2.24, 0.297, 142, 138, CRYSTAL STRUCTURE OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE COMPLEXED WITH 6-PHOSPHORYL-IMP GDP AND HADACIDIN
703, p3r9iD_, 0.5127, 3.34, 0.265, 160, 151, 2.6A RESOLUTION STRUCTURE OF MIND COMPLEXED WITH MINE (12-31) PEPTIDE
704, p3r9iA_, 0.5127, 3.61, 0.293, 162, 157, 2.6A RESOLUTION STRUCTURE OF MIND COMPLEXED WITH MINE (12-31) PEPTIDE
705, p3dl6A1, 0.5122, 3.61, 0.293, 162, 157, CRYSTAL STRUCTURE OF THE A287F/S290G ACTIVE SITE MUTANT OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS
706, p3r9iB_, 0.5121, 3.76, 0.136, 205, 154, 2.6A RESOLUTION STRUCTURE OF MIND COMPLEXED WITH MINE (12-31) PEPTIDE
707, p3r9iC_, 0.5119, 3.76, 0.136, 205, 154, 2.6A RESOLUTION STRUCTURE OF MIND COMPLEXED WITH MINE (12-31) PEPTIDE
708, d1iweB_, 0.5118, 3.72, 0.137, 204, 153, IMP COMPLEX OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE
709, d1lnyA_, 0.5116, 3.51, 0.260, 153, 146, CRYSTAL STRUCTURE OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE COMPLEXED WITH 6-PHOSPHORYL- IMP GDP AND MG
710, d1j4bA_, 0.5112, 2.82, 0.309, 148, 123, RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE
711, d1mf0A_, 0.5098, 2.86, 0.309, 144, 123, STRUCTURE OF THE RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE COMPLEXED WITH AMP GDP HPO4(2-) AND MG(2+)
712, d2v40A_, 0.5092, 4.75, 0.081, 349, 160, HUMAN ADENYLOSUCCINATE SYNTHETASE ISOZYME 2 IN COMPLEX WITH GDP
713, d2dgnA_, 0.5092, 4.87, 0.100, 349, 160, MOUSE MUSCLE ADENYLOSUCCINATE SYNTHETASE PARTIALLY LIGATED COMPLEX WITH GTP 2 -DEOXY-IMP
714, p4itnA1, 0.5075, 4.80, 0.094, 342, 160, CRYSTAL STRUCTURE OF COMPACT P-LOOP LPXK FROM AQUIFEX AEOLICUS IN COMPLEX WITH CHLORIDE AT 2.2 ANGSTROM RESOLUTION
715, p3dl6B1, 0.5070, 4.74, 0.089, 353, 158, CRYSTAL STRUCTURE OF THE A287F/S290G ACTIVE SITE MUTANT OF TS-DHFR FROM CRYPTOSPORIDIUM HOMINIS
716, p3um6A1, 0.5057, 4.70, 0.094, 336, 159, DOUBLE MUTANT (A16V+S108T) PLASMODIUM FALCIPARUM DHFR-TS (T9/94) COMPLEXED WITH CYCLOGUANIL NADPH AND DUMP
717, d1looA_, 0.5056, 4.64, 0.095, 358, 158, CRYSTAL STRUCTURE OF THE MOUSE-MUSCLE ADENYLOSUCCINATE SYNTHETASE LIGATED WITH GTP
718, p4dpdA1, 0.5051, 4.64, 0.095, 358, 158, WILD TYPE PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) DHF COMPLEX NADP+ DUMP
719, p3qgtA1, 0.5051, 1.98, 0.319, 116, 113, CRYSTAL STRUCTURE OF WILD-TYPE PFDHFR-TS COMPLEXED WITH NADPH DUMP AND PYRIMETHAMINE
720, p3um5A1, 0.5050, 4.77, 0.089, 310, 157, DOUBLE MUTANT (A16V+S108T) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS-T9/94) COMPLEXED WITH PYRIMETHAMINE NADPH AND DUMP
721, p4dphA1, 0.5048, 4.85, 0.089, 311, 158, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH P65 AND NADPH
722, p4dpdB1, 0.5048, 4.89, 0.089, 289, 157, WILD TYPE PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) DHF COMPLEX NADP+ DUMP
723, p3um8A1, 0.5043, 4.69, 0.063, 303, 158, WILD-TYPE PLASMODIUM FALCIPARUM DHFR-TS COMPLEXED WITH CYCLOGUANIL AND NADPH
724, p4dp3B1, 0.5039, 4.79, 0.090, 289, 156, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH P218 AND NADPH
725, p3um6B1, 0.5037, 4.70, 0.057, 308, 158, DOUBLE MUTANT (A16V+S108T) PLASMODIUM FALCIPARUM DHFR-TS (T9/94) COMPLEXED WITH CYCLOGUANIL NADPH AND DUMP
726, p4dphB1, 0.5036, 4.65, 0.088, 205, 148, QUADRUPLE MUTANT (N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS) COMPLEXED WITH P65 AND NADPH
727, p3qg2A1, 0.5036, 4.65, 0.088, 205, 148, PLASMODIUM FALCIPARUM DHFR-TS QRADRUPLE MUTANT (N51I+C59R+S108N+I164L V1/S) PYRIMETHAMINE COMPLEX
728, p3um5B1, 0.5035, 4.76, 0.103, 308, 156, DOUBLE MUTANT (A16V+S108T) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (PFDHFR-TS-T9/94) COMPLEXED WITH PYRIMETHAMINE NADPH AND DUMP
729, p3um8B1, 0.5034, 4.57, 0.052, 287, 154, WILD-TYPE PLASMODIUM FALCIPARUM DHFR-TS COMPLEXED WITH CYCLOGUANIL AND NADPH
730, p3qg2B1, 0.5032, 4.76, 0.057, 306, 157, PLASMODIUM FALCIPARUM DHFR-TS QRADRUPLE MUTANT (N51I+C59R+S108N+I164L V1/S) PYRIMETHAMINE COMPLEX
731, p3jsuB1, 0.5032, 4.82, 0.079, 250, 151, QUADRUPLE MUTANT(N51I+C59R+S108N+I164L) PLASMODIUM FALCIPARUM DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE(PFDHFR-TS) COMPLEXED WITH QN254 NADPH AND DUMP
732, d5i34A_, 0.5029, 4.81, 0.073, 250, 151, ADENYLOSUCCINATE SYNTHETASE FROM CRYPTOCOCCUS NEOFORMANS COMPLEXED WITH GDP AND IMP
733, p3qgtB1, 0.5027, 4.81, 0.073, 430, 150, CRYSTAL STRUCTURE OF WILD-TYPE PFDHFR-TS COMPLEXED WITH NADPH DUMP AND PYRIMETHAMINE
734, d1dj3A_, 0.5015, 4.82, 0.073, 431, 150, STRUCTURES OF ADENYLOSUCCINATE SYNTHETASE FROM TRITICUM AESTIVUM AND ARABIDOPSIS THALIANA
735, d1dj2B_, 0.5005, 4.74, 0.087, 257, 150, STRUCTURES OF ADENYLOSUCCINATE SYNTHETASE FROM TRITICUM AESTIVUM AND ARABIDOPSIS THALIANA
736, p5hcnA_, 0.5002, 4.74, 0.087, 257, 150, GPN-LOOP GTPASE NPA3 IN COMPLEX WITH GMPPCP
